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INTRODUCTION TO QUANTUM DOT BIOCONJUGATES 
Introduction and scope of the study 
Nanochemistry derives its name from the fact that the nanometer - one billionth 
of a meter - is its basic measuring unit. In the nanoworld, the width of the average human 
hair (about 80,000 nm) is huge. One nanometer is roughly the width of five carbon atoms. 
Metal and semiconductor nanoparticles (NPs) in the 2-6 nm size range are of 
considerable current interest, not only do to their unique size-dependent properties, but 
also because of their dimensional similarities with biological macromolecules ( e.g. most 
proteins are about 10 nm wide and a virus is about 100 nm long) [ 1-4]. These similarities 
could allow an integration of nanotechnology and biology, leading to major advances in 
medical diagnostics, targeted therapeutics, molecular biology and cell biology [5]. 
Recent research by several groups has linked colloidal NPs to bio-molecules such 
as peptides [6], proteins [7-9], and DNA [10,11]. These nanoparticle bioconjugates are 
being used for assembling new materials [12,13], for developing homo-geneous 
bioassays [ 14-16], and as multicolor fluorescent labels for ultrasensitive detection and 
imaging [7-11]. 
NPs possess several valuable qualities that are very attractive for fluorescent 
tagging: broad excitation spectrum, narrow emission spectrum, precise tunability of their 
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emission peak, longer fluorescence lifetime than organic fluorophores and negligible 
photo bleaching. 
The purpose of this chapter is to explain aspects of the synthesis, optical 
properties, surface chemistry, and biological applications of semiconductor NPs, also 
known as quantum dots (QDs), often composed of atoms from groups II-VI or III-V 
elements in the periodic table. QDs are defined as particles with physical dimensions 
smaller than the exciton Bohr radius [1-4]. For example, for spherical CdSe particles, this 
definition applies when the particle diameter is less than -10 nm. The effect of quantum 
confinement results in unique optical and electronic properties that are not available in 
either discrete atoms or in bulk solids. Carrier confinement in all three dimensions results 
in size dependence of QDs optical properties, including light absorption, 
photoluminescence (PL), electroluminescence (EL) [17-20] and cathodoluminescence 
(CL) [9,21]. Additionally, nanocrystal QDs can be chemically manipulated like large 
molecules. 
The combination of tunable electronic energies and chemical flexibility makes 
QDs ideal building blocks for biological applications. Recent work has demonstrated the 
dramatic benefits of QDs, including long-term photostability, high brightness, multi-
target labeling with several colors, and single-source excitation for all colors of QDs. 
New avenues of research are being developed using QD conjugates in live cell analysis. 
Most reported examples of QD conjugation to biomolecules are based on 
CdSe/ZnS core-shell colloids prepared in high boiling temperature organic solvents. The 
scope of this dissertation encompasses the development of novel bioconjugation 
approaches using different semiconductor materials: cadmium telluride (CdTe) and 
2 
core/shell cadmium selenide /cadmium sulfide (CdSe/CdS) quantum dots, synthesized in 
water, which significantly simplifies the preparation procedure. The challenges to using 
QDs for biological studies are threefold: (1) designing hydrophilic QDs that are 
luminescent, with surface chemistry adaptable to varied biological applications; (2) 
developing versatile techniques for selectively and specifically labeling cells and 
biomolecules; and (3) demonstrating that bioconjugates of QDs do not interfere with 
normal physiology. This dissertation addresses these concerns. 
Besides this introductory chapter, this dissertation contains three additional 
chapters with different nanoparticle-biomolecule conjugation approaches. Chapter II 
describes the conjugation of luminescent CdTe NPs with a simple protein, bovine serum 
albumin (BSA), reports the structure of protein-NP conjugates, and describes their optical 
properties. Chapter III further elaborates on the bioconjugation of NPs with proteins as 
(1) a method for their organization in more complex structures and (2) a pathway to new 
sensing and imaging technologies. In this chapter, the preparation of bioconjugates from 
an antigen and an antibody conjugated to NPs of different sizes is described. It is 
demonstrated that the NP-labeled antigen and antibody form an immunocomplex, which 
pairs together NPs with red and green luminescence. Chapter IV presents the results of 
the combination of developed bioconjugation procedures in order to design new NP 
conjugates for cell targeting that will be photo stable, water soluble and biocompatible. 
Obtained bioconjugates were applied for cell labeling by our collaborators at University 
of Texas Medical Branch (Galveston, TX). 
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Potential of quantum dots in biochemistry 
With the completion of the Human Genome Project and the cataloging of all gene 
sequences, biological and biomedical investigations are now focusing on how the tens or 
hundreds of thousands of proteins in a single cell function and interact with each other. A 
promising approach is fluorescence microscopy which has exquisite sensitivity down to 
the single-molecule level together with high spatial and subcellular resolution [22,23]. 
Because most cellular functions are accomplished by many proteins working together, a 
clear need exists to study multiple biological targets simultaneously in the cell. This goal 
has driven the development of new fluorescent labels that permit multiplexed labeling of 
cellular targets. 
Colloidal semiconductor nanocrystal QDs are luminescent inorganic fluorophores 
that have the potential to overcome some of the functional limitations encountered by 
organic dyes in fluorescence labeling applications. 
Small organic dyes commonly used for diagnostics applications and in biological 
imaging [24] have characteristics that limit their effectiveness in these applications. 
Problems with organic fluorophores include narrow excitation bands and broad 
emission spectra, which can make detection of multiple light emitting probes difficult do 
to spectral overlap and low resistance to chemical degradation and photodegradation [25]. 
Fluorescent QDs have size-dependent tunable photoluminescence (PL) with broad 
excitation spectra and narrow emission bandwidths (full width at half maximum of -30-
45 nm) that span the visible spectrum [20,21,26-28], which allows for simultaneous 
excitation of several particle sizes at a single wavelength. In addition QDs have high 
photochemical stability, excellent resistance to chemical degradation and 
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photodegradation, and a good fluorescence quantum yield. Luminescence emission from 
QDs is detected at concentrations comparable to organic dyes by using conventional 
fluorescence methods, and individual QDs and QD-bioconjugates are easily observable 
by confocal microscopy [9,29]. 
History of semiconductor quantum dots 
Victorian-era glass-melt recipes for red and orange colors contain, essentially, 
dilute concentrations of NPs (from zinc and cadmium sulfides and selenides). The 
nineteen-century chemists created these NPs spontaneously (and unknowingly) during 
the glass manufacturing process. These glasses were used to create colored windows. 
However, these richly hued progenitors lacked the fluorescence of the currently used 
semiconductor QDs. 
Modem QD technology traces its origins, in part, to the mid-1970's quest for new 
answers to meet the worldwide energy crisis that renewed interest for devices capable of 
an efficient utilization of solar energy. Research in photoelectrochemistry (e.g., solar cell 
energy conversion) was tapping the semiconductor/liquid interface to exploit the 
advantageous surface area-to-volume ratio of nanocrystal particles for energy generation. 
A side product of these works was the exploration of their luminescent properties, and in 
particular the relationship between nanocrystal size and fluorescence properties [3,30-
32]. 
Seminal development arose in the early 1980's from two laboratories, located far 
apart: Dr. Louis Brus at Bell Laboratories, and Drs. Alexander Efros and A.I. Ekimov of 
the Y offe Institute in St.Peterburg (then Leningrad) in the former Soviet Union. Two Bell 
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Labs scientists, introduced to this field by Dr. Brus - Dr. Moungi Bawendi and Dr. Paul 
Alivisatos - moved to MIT and UC Berkeley, respectively, and continued to investigate 
QD optical properties. Their pioneering work paved the way for the current QDs 
applications. 
Semiconductor QDs provide the opportunity to study the evolution of electronic 
behavior in a size regime intermediate between the molecular and bulk limits of matter. 
Quantum confinement 
Quantum confinement arises when one of the dimensions L of the object becomes 
of the order of the exciton Bohr radius: 
aex = (kfi2) I (mex *e2) 
where k is the semiconductor permittivity, mex is the reduced exciton mass, and e 
the electron charge ( for example, acuc1 = 7A, aoaAs = 100A and acdse= 56A). 
The first controlled synthesis and systematic studies of nanometer size 
semiconductor crystals in all three dimensions were performed by Ekimov and E:fros 
[33,34]. They studied quantum dot inclusions that were embedded in an insulating glass 
matrix. Ekimov' s sample was the first to exhibit the quantum-confined blue shift of the 
first absorption (exciton) peak, varying as a-2 (a being the nanocrystals radius) [33]. 
Solving the effective Hamiltonian for a spherical geometry, Al.L.Efros and A.L.E:fros 
computed the electron and hole energies in such a sphere and found a series of discrete 
lines, recovering the a-2 dependency observed in the experiment [34]. 
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The most useful outcome of quantum confinement for application is the 
discretization of the energy levels at the edges of conduction and valence bands upon 
dimensional reduction. Because QDs exhibit discrete structure in their optical and 
electrical characteristics, they are sometimes referred to as "artificial atoms", even though 
to a chemist, they appear to be very large and complex molecules [3]. 
Optical properties and detection 
The optical properties of semiconductor nanoclusters anse from interactions 
between electrons, holes, and their local environments. QDs emit light in a similar 
manner as a bulk semiconductor light-emitting diode (LED). However, LEDs are 
electrically activated, whereas QDs · are activated by the absorption of a photon of light. A 
semiconductor QD absorbs a photon when the excitation energy exceeds the bandgap. 
This absorbed photon of light creates an electron-hole pair. During this process, electrons 
are promoted from the valence band to the conduction band. 
Measurements of UV-visible spectra reveal a large number of energy states in 
QDs. The lowest excited energy state is shown by the first observable peak, known as the 
quantum-confinement peak. The created electron-hole pair quickly recombines leading to 
emission of a lower energy photon. In a semiconductor material, the energy of the 
emitted photon is determined by quantum confinement ( or the size of the QD). Moreover, 
QDs just a few angstroms different in size emit different wavelengths of light (Figure I-
I). This quantum mechanical physics [3,13,26,28,35-38] can be simply summarized: 
smaller QDs emit blue light, medium sized emit green/yellow light, and larger ones emit 
red light. 
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Figure 1-1. Ten distinguishable emission colors of ZnS capped CdSe QDs excited with a 
near-UV lamp. From left to right (blue to red), the emission maxima are located at 443, 
473,481, 500, 518, 543, 565,587,610, and 655 nm (Adopted from Ref. [39]). 
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Excitation at shorter wavelengths is possible because multiple electronic states are 
present at higher energy levels. In fact, the molar extinction coefficient gradually 
increases towards shorter wavelengths. This is an important feature for biological 
applications because it allows simultaneous excitation of multicolor QDs with a single 
light source. 
Light em1ss10n anses from the recombination of mobile or trapped charge 
earners. The emission from mobile earners is called excitonic fluorescence and is 
observed as a sharp peak. The excited-state lifetimes of nanocrystals contain three 
exponential components. In bulk measurements, the lifetimes are 5 ns, 20-30 ns, and 80-
200 ns, with 20-30 ns dominating [40]. These excited-state decay rates are slightly 
slower than those of organic dyes (1-5 ns), but much faster than those of lanthanide 
probes (1 s-1 ms). Single-dot measurement further reveals that the excited-state lifetimes 
are dependent on the emission intensity, but the exact origins of this multi-exponential 
behavior remain unclear. 
Difference between optical properties of semiconductor QDs and typical dyes 
The applicability of QDs as luminescent probes is summarized in Table I-1 [41], 
where their properties are compared with those of traditional dyes. From this table, it is 
evident that although not yet a panacea, QDs present considerable advantage over 
conventional organic dyes. 
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Table 1-1. Desirable features of a luminescent probe: comparison of the properties of 
conventional :fluorescent probes and quantum dots. 
Property Fluorescent Quantum 
probe dot probe 
1 Broadband excitation xa ,jb 
2 Narrow bandwidth X ,! 
em1ss1on 
3 Emit light of high intensity moderate ,! 
4 Available in many colors ,! ,! 
5 Readily attachable to ,! moderate 
analytes 
6 Resistant to quenching X ,! 
7 Photochemically stable X ,1c 
8 Cheap and readily ,! X 
available 
a X = "No" 
b -J = "Yes" 
c Quantum dots are prone to "blinking" [36] 
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In order to illustrate the information ih Table 1-1, as an example, the excitation 
and the emission spectra of a typical dye rhodamine 6G and CdSe QDs are shown in 
Figure 1-2 [39]. The QD emission spectrum is nearly symmetric and much narrower in 
peak width. Its excitation profile is broad and continuous. The QDs can be efficiently 
excited at any wavelength shorter than -530 nm. By contrast, the organic dye rhodamine 
6G has a broader and more asymmetric emission peak and is excited in a narrower 
wavelength range. 
Quantum yield (i.e., the number of photons emitted divided by number of photons 
absorbed) is a critical property of any fluorescent material. With a low quantum yield, the 
efficiency is very low, and so the signal intensity and sensitivity can be poor. 
In comparison to organic dyes such as rhodamine 6G and fluorescein, CdSe 
nanocrystals show similar or slightly lower quantum yields at room temperature, but the 
lower quantum yields are compensated by their larger absorption cross-sections and 
much reduced photobleaching rates. Bawendi and coworkers [26,28] estimated that the 
molar extinction coefficients of CdSe QDs are about 105 -106 M-1cm-1, depending on the 
particle size and the excitation wavelength. These values are 10-100 times larger than 
those of organic dyes, but are similar to the absorption cross-sections of phycoerytherin, a 
multichromophore fluorescent protein. Chan and Nie [7] estimated that single ZnS-
capped CdSe QDs are -20 times brighter and -100-200 times more stable than single 
rhodamine 6G molecules. 
The quantum yield of most organic dye molecules is reduced, sometimes to zero, 
upon conjugation to biomolecules. Some QD conjugates have quantum yields up to 80% 


















Curront Opinion n Biotedlnotogy 
Figure 1-2. Comparison of the excitation and the emission profiles between Rhodamine 
60 (red) and CdSe QDs (black). (a) excitation profile, (b) emission profile (Adopted 
from reference [39]). 
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Epifluorescence microscopy 
QDs can be used immediately in exciting epifluorescence microscopes that are 
equipped with dye-optimized filter sets. The broad absorbance spectrum of the QD 
allows a unique possibility in lamp-based fluorescent microscopes. The integrated 
absorbance across a broader excitation band is substantially higher than any single 
wavelength value. Using a lamp with a short-pass filter allows highly efficient excitation 
of the QDs with a much larger proportion of the lamp energy utilized. The narrow 
emission spectra of QDs allow the use of narrower emission filters compared to dye filter 
sets. The narrow bandpass filters reject more of sample autofluorescence (increasing 
signal to noise ratio). 
The QD emission is very photostable. This makes the QDs very easy to be 
scanned without concerns of losing the fluorescence image. Quantitative analysis may 
also be simplified, as photobleaching effects are removed. High photostability also allows 
the use oflong integration times, to improve sensitivity and signal-to-noise ratio. 
Confocal microscopy 
QD bioconjugates are ideal for confocal microscopy. The broad excitation allows 
the use of any of several commonly available lasers. QDs allow true multicolor confocal 
anlysis since all of the QDs can be excited by a single laser source. This removes issues 
such as accurate laser alignment or excitation chromatic effects. The high photostability 
exhibited by the QDs is especially valuable for confocal microscopy. When data is being 
gathered from one image plane, other planes remain illuminated by the laser source. In 
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the case of organic dyes, out-of-plane images may be unintentionally photobleached, 
leading to inaccurate measurements. Out-of-plane QDs remain highly luminescent. 
In confocal microscopes, a very high power density may be achieved through the 
use of a highly focused laser. Leaving photobleaching effects aside, the light emitted 
from an organic dye increases with increasing power density only up to the point of 
saturation of the dye, according to the "excited state lifetime" of the dye (i.e., the time 
between absorption of a photon and emission of a photon from a dye molecule). In the 
excited state, the organic dye is unable to absorb another photon; therefore, saturation 
occurs at high power densities. The excited state of QDs is approximately 12 ns, 
compared to around 2 ns for an organic dye. 
Blinking, where single QDs change from a "dark" to an "active" state, has been 
reported [36] and could be expected to reduce the signal from a QD assay. 
QDs have been reported to be efficiently excited in a dual- or multi-photon mode 
[ 42]. However, the author is not yet aware of any literature results that describe the use of 
QD conjugates in multi-photon microscopy. 
Synthesis of quantum dots 
There are two distinct synthetic routes to semiconductor nanostructures: in the 
first "physical" approach, they are grown by lithographic or molecular beam techniques, 
and in the second "chemical" approach, they are formed either by particle growth in solid 
(glass) matrices or by methods of colloidal chemistry. 
Typically, the wet-chemical preparation of NPs is carried out in the presence of 
stabilizing agents (often citrate, phosphanes, or thiols) which bind to the atoms exposed 
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at the surface of the NPs. This capping leads to a stabilization and prevents uncontrolled 
growth and aggregation of the NPs. This approach allows production of stable colloids of 
nanocrystalline particles, which are easily processable and can be handled like ordinary 
chemical substances. 
Colloids of II-VI crystallites were first prepared by arrested precipitation in 
homogenous solution [43,44]. Before 1993, QDs were mainly prepared in aqueous 
solution with added stabilizing agents ( e.g. thioglycerol or polyphosphate). This 
procedure yielded low-quality QDs with poor fluorescence efficiencies and large size 
variations (relative standard deviation [RSD]> 15% ). 
In 1993, Bawendi and coworkers [26] synthesized highly luminescent CdE (E= S, 
Se, Te) QDs by using high-temperature organometallic procedure via the reaction below: 
300°C, HDA-TOPO-TOP Q-CdSe + 
The nanocrystals had nearly perfect crystal structures and narrow size variations 
([RSD] <5%), but the fluorescence quantum yields were still relatively low (- 10%) 
A recent excellent contribution in this area is the large-scale synthesis of high-
quality QDs. Peng et al. [45] described the synthesis of CdTe, CdSe, and CdS NPs in 
large quantities using inexpensive starting materials and also developed procedures for 
controlling the surface structure of QDs and for producing stable QDs with red emissions. 
Various II-VI QDs have been prepared in aqueous solutions by the metathesis 
reaction as shown below: CdS [46], CdSe [47], CdTe [48], CdxHg1_xTe [49] and HgTe 
[50]. 
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100°C, H20, thiol 
Q-CdTe + · · ·. 
The presence of different thiols (thioethanol, thioglycerol, thioglycolic acid, 
dithioglycerol, mercaptoethylamine, etc.) as stabilizing agents and capping ligands allows 
control over the particle size during the synthesis (a size range of 2.0-8.0 nm is generally 
possible). 
The advantages of the aqueous synthesis are low-cost, reproducibility and the 
simplicity of mass production. 
Synthesis of core/shell quantum dots 
Some examples of core-shell quantum dot structures reported earlier include CdS 
on CdSe and CdSe on CdS [51], ZnS grown on CdS [52], ZnS on CdSe and the inverse 
structure [53], CdS/HgS/CdS quantum dot quantum wells [54], ZnSe overcoated CdSe 
[55], and Si02 on Si [56,57]. 
Overcoating NPs with higher band gap inorganic materials has been shown to 
improve the photoluminescence quantum yields by passivating surface nonradiative 
recombination sites. Particles passivated with inorganic shell structures are more robust 
than organically passivated dots and have greater tolerance to processing conditions 
necessary for incorporation into solid state structures. 
The deposition of a surface-capping layer such as ZnS or CdS was found to 
dramatically increase the quantum yields of CdSe NPs up to 40-50% at room 
temperature [27,28,38]. ZnS has a wider bandgap (energy difference between the valence 
band and the conduction band) than CdSe, but the Zn-S bond length is similar to that of 
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Cd-Se. This property allows the epitaxial growth of a thin ZnS layer on the CdSe core. 
In practice, the Zn(CH3)2/S solution is added slowly in small aliquots to a CdSe/tri-n-
octylphosphine oxide (TOPO, a high boiling point and coordinating solvent) solution to 
prevent ZnS nucleation. 
Surface chemistry 
The complex surface chemistry of nanocrystals has been studied by NMR 
spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR) and X-ray photoemission 
spectroscopy (XPS) [58,59]. Morphologically, QDs are not smooth spherical particles, 
but are faceted with many planes and edges. QDs are generally considered to be 
negatively charged owing to molecules adsorbed on the surface [60]. 
Capping quantum dots for biological application 
A key requirement for the successful use of QDs in biological applications is 
aqueous solubility. 
Most QDs used for biological applications were generally produced with a 
capping layer composed of one or more organic ligands such as trioctylphosphine (TOP) 
or trioctylphosphine oxide (TOPO). These ligands are hydrophobic and thus QDs capped 
with these coatings are not compatible with aqueous assay conditions. 
To make the QDs water soluble, these organophilic surface species are generally 
exchanged with more-polar species, and both monolayer [7] and multilayer [8] ligand 
shells have been pursued. Although the monolayer method is reproducible, rapid, and 
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produces QDs with a regular, well oriented, thin coating, their colloidal stability is poor 
[61]. In contrast, the multilayer method yields QDs that are stable in vitro [62] , but the 
coating process is long and the coating is difficult to control. A more serious concern is 
that both approaches still produce QDs that tend to aggregate and adsorb nonspecifically. 
To resolve this problem, researchers have explored two additional coatings. First, 
the outer ligand shell of the QD has been overcoated with proteins adsorbed through 
hydrophobic or ionic interactions [9]. Other layers can then be added to allow 
conjugation with specific biomolecules. Indeed, this method has provided new reagents 
for fluoroimmunoassays [ 63]. Second, the outer ligand shell has been overcoated with 
surfactants or polymers to prevent nonspecific adsorption of biomolecules while still 
permitting bioconjugation. For example, silica coated QDs have been further modified 
with small monomers ofpoly(ethylene glycol) to reduce nonspecific adsorption [64]. 
Methods for conferring water solubility on semiconductor QDs prepared m 
hydrophobic environments remains an active topic of research. 
Bioconjugation of semiconductor quantum dots 
Analogous to the interactions that are abundant in many reaction centers of 
enzymes between the amino acid side chains and the metal centers, the interaction 
between organic ligands and the surface of an inorganic NP paves the way for the 
coupling of biomolecular recognition systems to generate novel materials. Although 
inorganic NPs can be prepared from various materials by several methods, ( as discussed 
above) the coupling and functionalization with biological components has only been 
performed with a limited number of chemical methods. 
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Some examples for QDs bioconjugation are summarized in Table I-2. The general 
schematic representation of methods to couple inorganic NPs and biomolecules is shown 
on Figure I-3. 
Current bioconjugation methods are schematically illustrated in Figure I-4. There 
are two general approaches to bioconjugation of QDs. The first approach is linking 
biomolecules covalently to the capping layer that surrounds each QD using conventional 
synthetic methodologies. The second approach is attachment of biomolecules to QDs via 
different non-covalent interactions. 
Covalent attachment of biomolecules to capped quantum dots 
Reactive functional groups on the surface of QDs can include primary amines, 
carboxylic acids, alcohols, and thiols. Primary amines react with carboxylic acids, 
catalyzed with a carbodiimide or sulfo N-hydroxysuccinimide ester, to form a stable 
amide bond [25]. The example of such covalent attachment is illustrated in Figure I-4 (a) 
where standard carbodiimide-based chemistry was used to couple both transferrin and 
IgG to mercaptoacetic acid-coated nanocrystals [7]. 
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Table 1-2. Coupling of inorganic nanoparticles and biomolecules.* 
Nano particle Ligand on the Functional group of Biomolecule Reference 
QD surface biomolecule 
ZnS HS-Cys gluthathione [65] 
CdS HS-Cys peptides [66] 
CdS Cd.l+, HS-(CH2)r DNA [67,68] 
OH[aJ 
CdSe/ZnSlbJ HS-(CH2)6- DNA [IO] 
CdSe/ZnS10J HS-(CH2)-COOH H2N-Lys immunoglobulin, [7] 
transferrin 
CdSe/CdS/SiOibJ 3-aminopropyl- NHS-biotin streptavidin [8] 
trimethoxysilane 
Sn02, Ti02 HOOC-(CH2)n- HOOC-Glu proteinstcJ 
NH2 
CdSe/ZnS101 Lipoic acid H2N-Lys1a1 leucine zipper [21] 
fusion proteins 
GaAs, InP phosphoramide s HOOC-Glu proteinslcJ [69] 
-NH2 
CdSe/ZnS dithiothreitol 5'-aminated [11] 
(DTT) oligonucleotides, 
DNA 
CdTe L-cysteine H2N-Lys BSA Chapter II 
and [70] 
CdTe Mercatoacetic H2N-Lys BSA, anti-BSA Chapter III 
acid and [71] 
CdSe/CdS L-cysteine H2N-Lys BSA Chapter 
IV 
(*) - Examples of chemical interactions used for the coupling of nanoparticles with 
biological macromolecules. [a] Adsorption through Coulombic interactions. [b] 
Core/shell nanoparticles. [ c] Proposed from related studies of nanoparticle binding to 













Figure 1-3. General schematic representation of methods to couple inorganic 
nanoparticles and biomolecules (FG=functional coupling group). Representative 
structures of typical linkers are listed beneath (see also Table 1-2). 
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(a) Blfunclional llnkage (d) Electrostatic attraction 







Curu111  Opnlon In Bllotechoology 
Figure 1-4. Schematic illustration of bioconjugation methods. (a) Use of a bifunctional 
ligand such as mercaptoacetic acid for linking QDs to biomolecules [7]. (b) TOPO-
capped QDs bound to a modified acrylic acid polymer by hydrophobic forces. (c) QD 
solubilization and bioconjugation using a mercaptosilane compound [8]. (d) Positively 
charged biomolecules are linked to negatively charged QDs by electrostatic attraction [9]. 
(e) Incorporation of QDs in microbeads and nanobeads [72]. 
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Another example is covalent attachment of N-hydroxysuccinimide ester activated 
biotin onto the surface of the quantum dots allowing subsequent streptavidin-
biomolecule conjugates to be immobilized [8]. 
In recent development, Arnheim and co-workers describe activating the free 
hydroxyl groups of bidentate ligand dithiothreitol (DTT) capped CdSe/ZnS quantum dots 
as carbonyl diimidazole (CDI) derivatives [11]. These CDI-activated quantum dots react 
readily with 5'-aminated oligonucleotides, simply by mixing and stirring, to form stable 
carbamate linkages. Pre-activating nanocrystals in this manner ensures that the coupling 
procedure is trivial and negates any requirement for additional coupling reagents, etc. 
Moreover, since such modified oligonucleotides are readily available commercially this 
immobilization technique has generic applicability for the quantum dot labeling of DNA. 
The methodology is not restricted to 5'-aminated oligonucleotides, in theory any 
molecule that possesses an appropriate nucleophilic center, such as the amino termini of a 
peptide or protein, may be labeled with quantum dots in analogous fashion. 
Non-covalent attachment of biomolecules to capped quantum dots 
Biomolecules may alternatively be attached to quantum dots by the whole 
spectrum of non-covalent interactions. 
In the case of nanoparticles that are stabilized by amomc ligands, the 
biomolecules are often coupled through noncovalent electrostatic interactions. (Figure I-
4 d). 
The first example of this kind of attachment was described by Alivisatos and co-
workers [8] who labeled cell nuclei with aqueous compatible, silanized CdSe/CdS 
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quantum dots via electrostatic and hydrogen bonding interactions with 
trimethoxysilylpropyl urea, a component of the silanized cap (Figure 1-4 c). 
A similar approach has been used by Mattoussi et al. [9] in which engineered 
positively charged recombinant fusion protein composed of a basic leucine zipper domain 
fused to a maltose binding protein domain was directly adsorbed onto negatively charged 
QDs stabilized with lipoic acid (Figure 1-3) through electrostatic interactions. 
Similarly, the adsorption of DNA . molecules to positive or neutral CdS 
nanoparticles has been studied in detail [67,68,73]. 
Another approach for linking biomolecules to nanocrystals is to use a thiol-
exchange reaction. Here, mercapto-coated QDs (prepared by direct adsorption) are mixed 
with thiolated biomolecules (such as oligonucleotides or proteins) [10,74]. After 
overnight incubation at room temperature, a chemical equilibrium is reached between the 
adsorbed thiols and the free thiols. In this case, immobilization is formally non-covalent 
since it arises as a result of displacement of some of the capping agents by the thiolated 
oligonucleotides. Willner et al. describe similar conditions for immobilizing thiolated 
oligonucleotides onto cystamine / thioethanesulfonate coated CdS quantum dots and 
estimate that between 20 and 24 oligonucleotides can be immobilized onto each 
nanoparticle [75]. 
The above examples demonstrate that some chemical means have already been 
explored for the physical linkage of inorganic and biological materials. However, there is 
still a great demand for alternative methods to allow for compensation of typical 
problems that arise in the biofunctionalization of inorganic nanoparticles. In particular, 
harsh reaction conditions often lead to the degradation and inactivation of sensitive 
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biological compounds, and ligand-exchange reactions that occur at the colloid surface 
often hinder the formation of stable bioconjugates. Moreover, the synthesis of 
stoichiometrically defined nanoparticle-biomolecule complexes is a great challenge, and 
is particularly important from a molecular engineering point-of-view to generate well-
defined nanoarchitectures. 
Some examples of biological application of quantum dots 
Bioconjugated QDs have been used in DNA hybridization [10], immunoassay [7], 
receptor-mediated endocytosis [7], and time-gated fluorescence imaging of tissue sections 
[40]. 
Alivisatos et al. and Nie et al. were the first to label biological cells with 
luminescent semiconductor nanocrystals (QDs) [7,8]. QD binding was achieved through 
non-specific interactions or through secondary binding to molecular receptors. In one 
case, nanocrystals were attached to cells through non-specific electrostatic/hydrogen 
bonding interactions or by using avidin and biotin molecules as intermediaries between 
the nanocrystal and the cell [8]. In another study, QDs were modified with transferrin 
protein for non-specific cellular uptake, or attached to immunoglobulin G (IgG) 
secondary antibodies [7]. 
An important advantage is that the extremely high photostability of QDs allows 
real-time monitoring or tracking of intracellular processes over long periods of time 
(minutes to hours). Another advantage is the ability to use multicolor nanocrystals to 
simultaneously image multiple targets inside living cells or on the cell surface. 
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Furthermore, with an inert layer of surface coating, the toxicity of Cd derivatives may be 
mediated. 
QD conjugates have been shown to detect the breast cancer marker Her2 on fixed 
cells, mouse mammary tumor sections, and on the surface of unfixed live cells [76]. The 
size of the QDs does not appear to have a significant effect: intracellular targets, 
including microtubules, actin filaments, nuclei, and mitochondria have been effectively 
labeled [76]. 
Also QDs have been injected inside living Xenopus embryos [77]. Authors of this 
paper reported that they were able to inject single cells with quantum dots. By following 
the QD :fluorescence during embryo development, cell lineage could be followed all the 
way to the tadpole stage. 
Endocytic uptake of QDs by cells has been demonstrated [78]. In this study, the 
cells appeared unaffected by the presence of the QDs over a period of more than a week. 
Furthermore, the QD :fluorescence signal remained detectable throughout this period. 
Nanocrystals are also emerging as a new class of :fluorescent labels for in vivo 
cellular imaging. QDs bearing co-adsorbed peptides and polyethylene glycol QDs 
conjugated to lung-targeting peptides were injected into mice and showed accumulation 
in the lungs [79]. QDs specific for blood vessels of lymphatic vessels in tumors were 
targeted in a similar manners. 
A further application of QDs is the multiplexed optical encoding and high-
throughput analysis of genes and proteins, as reported by Nie and coworkers [72]. 
Polystyrene beads are embedded with multicolor CdSe QDs at various color and intensity 
combinations. The use of six colors and 10 intensity levels can theoretically encode one 
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million protein or nucleic acid sequences. Specific capturing molecules such as peptides, 
proteins, and oligonucleotides are covalently linked to the beads and are encoded by the 
bead's spectroscopic signature. A single light source is sufficient for reading all the QD-
encoded beads. To determine whether an unknown analyte is captured or not, 
conventional assay methodologies (similar to direct or sandwich immunoassay) can be 
applied. This so-called 'barcoding' technology can be used for gene profiling and high-
throughput drug and disease screening. 
Conclusions 
Published papers demonstrate the successful application of bioconjugated 
quantum dots for labeling cells and macromolecular constituents of cells. 
QDs conjugates exhibit extremely desirable properties for biological 1magmg. 
Their photostability makes them easy to use and allows integration of signal to increase 
sensitivity. Many spectrally narrow QD colors can be created to allow simultaneous 
analysis of many conjugates. QDs can be excited by the same light source, simplifying 
the instrumentation. Quantum yield and excitation cross sections are very high giving 
very bright signals. The large difference between excitation and emission colors reduces 
autofluorescence and simplifies instrumentation. Immediate improvements can be 
realized using quantum dots in current immunostaining applications. 
In the future, QDs promise to open up new applications in live cell and whole 
organism imaging. As further colors and conjugates of QDs become widely used, a 
plethora of additional applications is anticipated. 
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CHAPTER II 
ALBUMIN-CdTe NANOPARTICLE BIOCONJUGATES: PREPARATION, 
STRUCTURE, AND INTERUNIT ENERGY TRANSFER 
WITH ANTENNA EFFECT1 
Introduction 
Fluorescence semiconductor nanoparticles (NPs) properties and applications stand 
among the most exciting research fields in chemistry, physics and biology. 
High quality nanocrystals of different II-VI semiconductor materials are currently 
available. One beneficial property of cadmium telluride CdTe NPs is the very stable 
luminescence that covers almost the whole visible spectral range depending on the 
particle size. CdTe NPs provide very high photoluminescence quantum efficiencies. The 
quantum efficiency value of 65% at room temperature has been reported for 
organometallically prepared CdTe NPs [1,2]. Unfortunately, potential applications of 
these NPs are limited due to instability of their photoluminescence in air. However, since 
the appearance of the first report on the aqueous synthesis of mercaptoethanol- and 
thioglycerol-capped CdTe NPs in 1996 [3], sufficient progress has been made in the 
preparation and the design of the surface properties of thiol-capped CdTe nanoparticles, 
1 The content of this Chapter has been published in Nano Letters, 2001, 1 (6), p.281-286. 
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as well as in their characterization [4,5]. These NPs have been used in numerous 
applications. Worth mentioning is the utilization of luminescent thiol-capped CdTe QDs 
in light-emitting devices (LEDs) [6-8], photonic [9-12] and core-shell structures [12-14]. 
Recent investigations have shown the attractive properties of this material for light 
energy conversion [15]. Summarizing the experimental data available today, thiol-capped 
CdTe nanoparticles synthesized in aqueous solution represent a relatively stable highly 
luminescent core-shell QD system with a naturally sulfur-capped surface (CdS shell) 
created by mercapto-groups covalently attached to the surface cadmium atoms that make 
them very attractive for fluorescent tagging. 
Although some of the photophysical properties of NP are not fully understood and 
are still actively investigated, researchers have begun developing bioconjugation schemes 
and applying such probes to biological assays. 
This chapter is concerned with the conjugation of luminescent CdTe NPs with a 
simple protein, bovine serum albumin (BSA). The purpose of this chapter is three-fold: 
(1) to present a simple method of protein-NP conjugation utilizing amino acid-coated NP 
and discuss its limitations, (2) to report on the structure of protein-NP conjugates, and (3) 
to describe their optical properties. 
As a convenient model for the fundamental studies of protein - NP conjugates 
BSA was chosen as one of the most studied proteins, whose structure and properties are 
known to the smallest details. Since albumin is a typical plasma protein, albumin-coated 
NPs are important for the study of their interactions with live blood cells and the immune 
response of the organism to their intravenous administration. Also, despite low 
biospecificity, BSA has a strong affinity to a variety of organic molecules binding to 
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different sites, which makes possible utilization of BSA-decorated NPs in a variety of 
supramolecular assemblies. For the conjugate preparation, glutaraldehyde (G) was used 
as a linker applicable to the majority of proteins. 
Experimental procedures 
Instrumentation 
A Hewlet-Packard HP-8453 diode array spectrophotometer was used to collect 
optical absorption spectra at room temperature using I-cm quartz cuvettes. 
Photoluminescence experiments were recorded at room temperature in 1 cm x 
1 cm quartz cuvettes on FluoroMax-3 and Fluorolog-3 spectrofluorometers from Jobin 
Yvon/ Spex, Horiba group (Edison, NJ) with use of front face or right angle collection 
with 5 nm slits. 
Circular dichoism (CD) spectra were recorded on a JASCO J-500A 
spectropolarimeter using a JASCO cell of 0.10 cm path length. 
Native and SDS-PAGE gel electrophoresis were performed on the Mini-
PROTEAN 3 electrophoresis cell (Bio-Rad, Hercules, CA) using precast gels. 
Reagents and materials 
All chemicals and biochemicals used in this work were of analytical grade or of 
highest purity available and were obtained from commercial sources. Cadmium 
perchlorate hydrate, 2-mercaptoethanol, L-cysteine, glutaraldehyde (25% aqueous 
solution), powder of phosphate buffered saline (PBS), pH 7.4 and bovine serum albumin 
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were purchased from Sigma - Aldrich Co. (St. Louis, MO, USA). Sodium hydroxide, 
glycine and tris(hydroxymethyl)aminomethane (Tris-base) were purchased from EM 
Science (Gibbstown, NJ, USA). Glycerin, ethylene glycol, sodium dodecyl sulfate (SDS) 
and (tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl) were obtained from 
Fisher Scientific (Fair Lawn, NJ, USA). Aluminum telluride was from Cerac Inc. 
(Milwaukee, WI, USA). Bromophenol blue was obtained from Eastman Kodak Co. 
(Rochester, NY, USA). Sulfuric acid was purchased from Pharmco (Brookfield, CT, 
USA). Rhodamine B was obtained from Fluka (Milwaukee, WI, USA). 
Bio-Safe colloidal Coomassie Blue G-250 stain, precast 4-20% linear gradient 
Tris-HCl gel plates used for native and SDS-PAGE electrophoresis, Kaleidoscope and 
SDS-PAGE prestained standards were purchased from Bio-Rad (Hercules, CA, USA). 
Spectra/Por dialysis membranes with molecular weight cutoff (MWCO) = 50,000 were 
from Spectrum Laboratories, Inc. (Rancho Dominguez, CA, USA). 
Deionized water (Barnstead) with 18.2 MQ/cm was used for all experiments. 
Synthesis of cadmium telluride (CdTe) nanoparticles 
L-cysteine-stabilized CdTe NPs were synthesized according to the standard 
technique of arrested precipitation in aqueous solution reported previously [3,16]. The 
typical experimental setup is pictured on Figure 11-1. 
Cd(Cl04)2 + H2 Te 100°C, H20 NaOH > Q-CdTe + ... 
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I 
Figure 11-1. Schematic presentation of the synthesis of thiol-capped CdTe QDs. First 
stage: formation of CdTe precursors by introducing H2 Te gas. Second stage: formation 
and growth of CdTe nanoparticles promoted by reflux (Adopted from ref. [17]). 
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Since L-cysteine is a hydrophilic stabilizer this method overrides the stages of 
silica coating and/or stabilizer exchange, which makes it simpler than the previously 
reported procedures of protein-NP composites [18,19]. At the same time, it is important 
to point out, that the protective encapsulation of NPs is necessary for prevention of their 
slow decomposition and nonspecific luminescence quenching. 
Briefly, in a typical synthesis as shown in Figure II-1 0.7741 g (2.35 mmol) of 
Cd(Cl04)2·H20 was dissolved in 125 mL of water, and 5.7 mmol of the thiol stabilizer 
(0.6906g of L-cysteine) was added under stirring, followed by adjusting the pH to 11.2-
11.8 by drop wise addition of 1 M solution of NaOH. Occasionally, the solution remained 
slightly turbid at this stage because of the incomplete solubility of Cd-thiolate complexes, 
but this did not influence the further synthesis. The solution was placed in a three-necked 
flask fitted with a septum and valves and was deaerated by N2 bubbling for -30 min. 
Under stirring, H2 Te gas (generated by the reaction of 0.2 g (0.46 mmol) of Ah Te3 lumps 
with 15-20 mL of 0.5 M H2S04 under N2 atmosphere) was passed through the solution 
together with a slow nitrogen flow for -20 min. The molar ratio of Cd2+:Te2-:L-cysteine 
was 1:0.47:2.43. CdTe precursors were formed at this stage accompanied by a change of 
the solution color from transparent to yellow. 
The CdTe precursors showed an absorption spectrum unstructured in the visible 
spectral region with a tail extending to 650-700 nm, and no luminescence. The precursors 
were converted to CdTe nanoparticles by refluxing the reaction mixture at 100 °C under 
open-air conditions with condenser attached (Figure II-1). A clearly resolved absorption 
maximum of the first electronic transition of CdTe QDs appeared at-420 nm in 5-10 min 
after beginning of reflux corresponding to the smallest CdTe NPs (<2 nm size) which 
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shifted to longer wavelengths as the particles grew in the course of heating. Green 
(luminescence maximum at -510-520 nm) band-edge emission appeared in 10-15 min 
after beginning of reflux when the CdTe NPs reached the size of -2 nm. The size of the 
CdTe QDs growth further was controlled by the duration of reflux and could easily be 
monitored by absorption and PL spectra. 
The same tendency was observed for the growth of CdSe NPs stabilized with thio 
acids or thioalcohols [20]. 
Determination of final concentration of CdTe nanoparticles 
Molecular weight (Mw) of the NPs is calculated according to the formula: 
Mw=p*NA*Vo 
where NA is the Avogadro number, p = 6.20 g/cm3 is the density of cadmium 
telluride[21], and V0 is the volume of one particle, that can be calculated, assuming 
spherical particle shape, according to the formula: 
Vo= 4/31rl = (1uf)/6 
where r is the radius, dis the diameter of the particle. 
Size of the particles was estimated to be - 2 nm by TEM (transmission electron 
microscopy). Thus, the volume of one particle Vo will be: 
Vo= (3.14*(2.0*10-9)3)/6 m3 = 4.19 *10-27 m3 = 4.19 *10-21 cm3 
Hence: 
Mw(NPs) = 6.20 g/cm3 * 6.02*1023 1/mol * 4.19 *10-21 cm3 = 
= 15626.29 g/mol ~ 15600 g/mol 
The reaction equation: 
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Cd(Cl04)2 + H2 Te + 2NaOH = CdTe + 2NaCl04 + H20 
The quantities of Cd(Cl04)2 and H2 Te were 2.35 mmol and 1.1 mmol respectively, hence, 
the number of moles (v) ofCdTe NPs will be: 
v(NPs) = (l.lmmol * Mw(CdTe))/Mw(NPs) 
v(NPs) = (l.lmmol * 240 g/mol) /15626.29 g/mol = 1.69 *10-5 mol 
Since the reaction volume Vwas 125 mL, the molarity of the NPs solution (M) 
will be: 
M= v(NPs)/V= l.69 *10-5 moll 0.125 L = 
= 1.35 *10-4 mol/L = 0.135 mmol/L. 
So that, the final concentration of CdTe NP was estimated to be 0.135 mM. 
Quantum yield determination 
The quantum yields of NPs luminescence ( <pNP) were determined by usmg 
Rhodamine B as a standard. The choice of the standard was based on the principle that 
the emission maxima of both the standard and unknown were comparable. Rhodamine B, 
in ethylene glycol, has an emission maximum at Amax =580nm, and its quantum yield ( <ps) 
integrated over the emission peak was taken as 1.0. Optical density of the NP dispersion 
in water (O~p) and that of the standard (ODs) at the excitation wavelength (350nm) 
were adjusted to be within 0.05 absorbance units within each other. The overall optical 
density of both solutions did not exceed 0.1 AU. The quantum yield was calculated by 
the formula: 
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where, INP and Is are the integrated areas of luminescence for NPs and standard 
respectively. 
Conjugation procedure 
The CdTe nanoparticles of ca. 2.0 nm size of the semiconductor core with band-
edge emission at 520 nm ( quantum efficiency 15% at room temperature) were used for 
conjugation. 
A one-step G linkage conjugation procedure (Figure 11-2) was used, previously 
shown to work well for the protein-protein conjugation [22-24] and for the preparation of 
self-assembled monolayers [25-27]. 
One aldehyde group of glutaraldehyde (G) (O=CH-(CH2)3-HC=O) forms a Schiff 
base linkage with the L-cysteine amino group on the surface of nanoparticles (NPs ), while 
the other side forms an identical bond with predominantly lysine moieties on albumin 
(BSA). 
In a typical preparation of the BSA-G-CdTe conjugate, 4 mL of obtained aqueous 
CdTe NPs solution was mixed with 0.150 mL of glutaraldehyde (25% in water) and 
0.625 mL of a 40 mg/mL solution of BSA in a pH 7.4 phosphate buffer, and 0.225 mL of 
phosphate-buffered saline (PBS, 0.01 M phosphate buffered saline, pH = 7.4, of the 
composition 0.138 M NaCl-0.0027 M KCl) was added. Final concentrations were as 
follows: [NP] = 0.11 mM, [G] = 0.0752 M, [BSA] = 5 mg/mL = 0.07 mM, which 
corresponds to molar ratios NP:G:BSA 1.5:103:1. After the mixture was incubated for 1hr 
at 60 °C, it was dialyzed ( 48 hrs, using Spectra/Por dialysis membranes with MWCO = 
50,000) against the PBS and placed in a refrigerator at 4 °C for storage. No subsequent 
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Hz H 
s-c-c-NH I z 
COOH + 
Hz Hz H H 
S-c-1-N,CHz};-N 
COOH + 
Figure 11-2. Conjugation nanoparticles with albumin using glutaraldehyde. 
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.... 
treatment with sodium borohydride (NaBH4) or sodium cyanoborohydride (NaCNBH3) 
was used because the excess of L-cysteine present in the mixture as a mild reducing agent 
converted the initially forming Schiff base into the secondary amine bond. 
The selection of proper conditions and reagent ratios resulted m a minimal 
formation of oligomers that is often mentioned as one of the disadvantages of 
glutaraldehyde coupling. 
Gel electrophoresis 
The cigar-shaped ellipsoidal molecules of BSA with hydrodynamic dimensions of 
40 A (short axis) by 140 A (long axis) are often used in gel electrophoresis assay as a 
molecular weight standard (Mw 67 kDa) [28]. Thus, the products of BSA-G-CdTe 
conjugation could be conveniently analyzed by this technique. 
Native and SDS-PAGE gel electrophoresis were conducted for analysis of 
conjugates. Precast 4-20% linear gradient Tris-HCl gel plates were used. Gel 
electrophoresis was run for 1.5 hrs at 82 V, 25 mA. A 10 µL aliquot of the sample was 
mixed with 2 µL of the sample buffer, and the appropriate amount (2-10 µL) of the 
mixture was injected into the gel plate to obtain well-resolved spots of desirable 
dimensions. 
Sample buffer for SDS-PAGE contained 50% glycerol, 25% 2-mercaptoethanol, 
10% SDS, 0.1 bromophenol blue, and Tris-HCl pH 6.8. SDS electrophoresis running 
buffer was made from 6.06 g of Tris base, 28.5 g of glycine, and 1.0 g of SDS dissolved 
in 1 L of water. 
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The sample buffer for native state gel electrophoresis was prepared from 15.5 mL 
of 1 M Tris-HCl pH 6.8, 2.5 mL of a 1 % solution of bromophenol blue, 7 mL of water, 
and 25 mL of glycerol. The electrophoresis running buffer was made by dissolving 3.0 g 
of Tris base and 14.4 g of glycine in water and adjusting the volume to 1 Lat pH 8.3. 
Luminescence in gel plates 
A 0.5 x 0.5 cm piece was cut out from the gel plate after separation of the 
conjugation products. The piece of gel was attached to a glass slide and placed in the 
sample compartment of a Fluorolog 3 instrument. The luminescence spectrum was 
obtained at the excitation wavelength of 360 nm. 
Circular dichroism 
BSA sample was dissolved in 0.01 M PBS buffer. A sample of CdTe, cysteine-
stabilized nanoparticles, and the conjugate sample were at pH 7.4. The initial solutions 
were diluted to approximately 1 mg/mL concentration of BSA immediately before the 
spectra were taken. 
Results and discussion 
Native and SDS gel electrophoresis 
In all samples, free CdTe NPs (Mw ~ 16 kDa, as estimated for a 2 nm CdTe core 
covered with a mono layer of L-cysteine ), compact and highly negatively charged, 
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traveled far ahead of BSA and were typically found at the lower edge of the gel plate 
with other components traveling with the electrophoretic front. The bands of BSA were 
always positioned in the middle of the gel plate and could be clearly identified by the 
comparison with the standard protein ladder (Figure II-3). CdTe NPs used were strongly 
luminescent with a quantum yield of 15-20%, while that for BSA under the best 
conditions was about 3%. Hence, the emission intensity of SDS-P AGE electrophoresis 
spots was used for the optimization of conjugation conditions. The yield of BSA-G-CdTe 
conjugate gradually increased with the increasing temperature of the reaction (Figure II-
3 a, wells 3-6). The yield reached the maximum at approximately 50 °C for 1 hr reaction 
time, as indicated by the strongest luminescence of the BSA band (Figure II-3 a well 6). 
For longer times and higher temperatures, the yield of BSA-G-CdTe decreased due to 
oligomerization reactions (Figure II-3 a, wells 7-9). Unfolding of BSA occurs above 
65 °C and is quite reversible unless extreme pH conditions are used [28]. 
More detailed information about the products of the conjugation reaction could be 
obtained from native gel electrophoresis data. Contrary to SDS-PAGE, the denaturation 
of the protein caused by the addition of SDS does not occur in this technique and the 
protein retains its original charge, which makes it more informative. 
When BSA was mixed with NPs without coupling agent (Figure II-3 b, wells 4 
and 5), the luminescence of the BSA band was very weak regardless the time of 
exposure, while all NPs were run off the gel plate. Importantly, this demonstrated that 
there is very little, if any, nonspecific binding ofNPs to BSA. The BSA bands in wells 4 
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Figure 11-3. Luminescence images of SDS PAGE and native gel electrophoresis assays 
of BSA-G-CdTe conjugates. a) SDS PAGE assay. Wells: (1) CdTe; (2) BSA; (3) CdTe + 
BSA (no G); (4) CdTe + G + BSA heated at 25 °C 1 hr; (5) CdTe + G + BSA heated at 40 
°C for I hr; (6) CdTe + G + BSA heated at 50 °C for 1 hr; (7) CdTe + G + BSA heated at 
60 °C for 1 hr; (8) CdTe + G + BSA heated at 60 °C for 1.5 hrs; (9) CdTe + G + BSA 
heated at 60 °C for 2 hrs. The standard protein prestained ladder with spot marked BSA 
was run on the same gel plate. (b) The native gel electrophoresis assay. Wells: (1-3) (all 
the same) CdTe + G + BSA heated at 50 °C for 1 hr; (4-5) CdTe + BSA (no G); (6-7) 
BSA. The molecular weight scale on the left was graduated by the positions of reference 
proteins in the standard protein ladder given on the right with BSA spot marked. 
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and 5 were slightly shifted to higher molecular weights as compared to pure BSA in NP-
free buffer (Figure II-3b, wells 6 and 7). This occurred due to the complexation of Cd2+ 
ions present in colloidal solution of CdTe by metal-binding sites for which BSA is well-
known (28,29]. The net charge per one BSA molecule is -19 at pH 7.4 [28]. The addition 
of Cd2+ reduced the negative charge of BSA and resulted in lowering its electrophoretic 
mobility. As expected, this shift disappeared when the protein was denaturated by sodium 
dodecyl sulfate in the SDS-PAGE electrophoresis experiment (Figure II-3 a). Cd2+ ions 
may be present in solution both due to incomplete removal by the dialysis as well as due 
to slow decomposition of the NPs caused by the exposure to light and oxygen. Regardless 
of the origin, for any biomedical applications of NPs, it is important to minimize the 
presence of heavy metals because of their cytotoxicity. 
Two new strong luminescent bands appeared after addition of G and incubating 
the reaction mixture at 50 °C for 1 hr (Figure 11-3 b, wells 1-3). By using the standard 
protein ladder as a reference, the molecular weights of the conjugation products were 
determined to be 82 and 150 kDa. As it was demonstrated later, the use of Mw from gel 
plates has to be done very cautiously because the mass addition of NPs, which are 
compact and highly charged, may not follow the dependence of the SDS-PAGE shifts 
calibrated for proteins. The position of the band at 82 kDa matched the sum of masses of 
BSA (67 kDa) and NP (16 kDa), and therefore, should be attributed to 1:1 BSA:CdTe 
conjugate (-83 kDa), although the coincidence may be fortuitous. At the same time, the 
mobility of the conjugate has not significantly changed in respect to the BSA-CdTe 
mixture (Figure II-3 b, wells 4 and 5). It may be suggested that the added weight and high 
negative charge associated with the formation of the BSA-G-CdTe diad partially 
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compensate each other. The band at 150 kDa should be attributed to a 2:1 BSA-CdTe 
conjugate with an estimated mass of 152 kDa. Unlike the case of NP-DNA conjugates 
[30], the attachment of a greater number of BSA units to CdTe did not occur, most likely 
due to the steric hindrances related to the difficulty with the accommodation of bulky 
protein units around relatively small NPs (2 nm). 
The electrophoresis experiment has been performed in a variety of conditions and 
no further separation of the luminescence bands has been noticed. Although no direct 
evidence indicates the formation of conjugates with two or more CdTe attached to one 
albumin unit, the possibility of their formation should also be considered and may 
contribute to broadening the 1: 1 conjugate band. Importantly, virtually no byproducts, 
such as (BSA-G-NP)n oligomers, were present in solution, as could be seen by the 
absence of luminescent bands for masses above 150 kDa, which was one of the goals of 
the optimization of reaction conditions. 
Luminescence in gel plates 
To confirm the binding of CdTe to BSA, the luminescence spectrum of the 82 
kDa band in the native gel electrophoresis was obtained. The spot on the gel plate 
corresponding to this band had noticeably yellow coloration indicative of CdTe NPs. 
The luminescence spectrum of the gel piece showed a characteristic band-edge 
emission peak of CdTe red-shifted by -25 nm from its original position in the NP 
solution (Figure 11-4). 
A series of additional experiments showed that this shift was caused by the 
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Figure 11-4. Comparison of photoluminescence emission spectrum of band cut out from 
the native state electrophoresis gel plate to the corresponding spectra of NPs in solution. 
Luminescence spectra of (1) 82 kDa band cut out from the native state electrophoresis gel 
plate, (2) CdTe as synthesized, (3) CdTe + G (no BSA) heated at 50°C forl hr, and (4) 
CdTe (no BSA, no G) heated at 50 °C forl hr. Excitation wavelength 11,ex = 360 nm. 
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result in the luminescence spectral shift (Figure II-4, trace 4). The quantum yield of NP 
excitonic emission for 360 nm excitation did not change appreciably after the reaction 
with G or BSA and decreased by 1-3% during heating without conjugation. 
Circular dichroism 
Circular dichroism spectra of BSA and BSA-G-CdTe are represented on 
Figure II-5. 
Circular dichroism spectra indicate a small disturbance of the BSA conformation 
observed as a curve shift in 210-214 nm range as expected when highly charged species, 
such as NPs, are conjugated to protein molecules. Also, the circular dichroism spectra 
coincided well with each other and with reported BSA data [31]. This shows that the 
tertiary structure of BSA remains mostly intact that is essential for the preparation of 
protein-based assemblies ofNPs. 
Luminescence and adsorption spectra 
Luminescence spectra are shown on Figure II-6. Excitation wavelength A.ex was 
290 nm. The concentration ofNPs and their optical density at 290 nm were kept the same 
for all the experiments. 
In aqueous solution, free BSA emitted at 340 nm (Figure II-6, trace 1). This 
emission peak originated from the luminescence of two aromatic tryptophan moieties 
present in BSA amino acid sequence: Trpl34 and Trp 214 [28]. Simple addition of 
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Figure 11-6. Photoluminescence emission spectra of BSA, NPs, their mixture and BSA-
G-CdTe conjugate. (a) Luminescence spectra of (1) BSA, (2) BSA + CdTe (no G), (3) 
CdTe heated at 50 °C for 3 hrs (no G, no BSA), (4) CdTe + G heated at 50 °C for 1 hr, 
and (5) BSA + CdTe + G heated at 50 °C for 1 hr. (b) Gel electrophoresis of BSA + CdTe 
(wells 1 and 2) and BSA-G-CdTe conjugate (wells 3 and 4) carried out in 18% Tris-HCl 
Gel (Bio-Rad, 18% resolving gel , 4% stacking gel) for 45 min to resolve the band of the 
NP and to avoid gel edge effects. 
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band by ca. 2.5 times, while the NP luminescence did not significantly change (Figure 11-
6, trace 2). This can be understood as a response to, among other factors, the change in 
pH and presence of Cd2+ ions, which alters the presentation of Trp moieties to water and 
the efficiency of quenching their luminescence by ambient oxygen. 
Interestingly, the produced BSA-G-NP conjugates demonstrated effective 
interaction between the excited states of the biological and the inorganic parts. This effect 
should be attributed to the spatial closeness of BSA and NP in the tightly bound covalent 
supramolecule. 
The emission intensity of both biological and inorganic components changed 
dramatically in the BSA-G-CdTe conjugates. The luminescence of BSA was quenched 
completely, while the excitonic peak of CdTe increased ca. 2-fold in amplitude and 2.8-
fold in the area under the curve (Figure 11-6, trace 5). All the spectra were taken for 290 
nm excitation, where both BSA and NP absorb light. Since there was no major change in 
the quantum yield for long wavelength excitation, such a strong increase in luminescence 
efficiency of NPs is quite remarkable. The strong increase of the luminescence after the 
conjugation can also be seen in the gel-electrophoresis taken for the short running times 
(Figure 11-6 b). The bands of the conjugates not yet separated are noticeably brighter 
(Figure 11-6 b wells 3 and 4) than the band ofunconjugated NP (Figure 11-6 b wells 1 and 
2). In addition, in this image, one can also see that the relative amount of unconjugated 
NP for BSA-G-CdTe is negligible. 
The luminescence enhancement effect can be associated with the concentration of 
adsorbed energy collected by NP from protein unit(s) through the resonance energy 
transfer [32] analogous to the classical Forster energy transfer [33]. The excitation energy 
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transfer from protein to the excitonic state of NP can be confirmed by the excitation 
spectrum ofBSA-G-CdTe conjugates registered in the emission band of CdTe (Figure II-
7). The excitation peak of the BSA-G-CdTe conjugate at 280 nm (Figure II-7 a, trace 1) 
coincided very well with UV-vis absorption peak of BSA (Figure II-7 b, trace 1 ). 
Concomitantly, there was no similar band in the excitation spectrum of CdTe 
reacted with G (Figure II-7 a, trace 2) or in their UV-vis absorption spectrum (Figure II-
7 b, trace 2). This data indicates that the quanta of light absorbed by BSA are emitted by 
the CdTe. For conjugates bearing two BSA units, the NP collects the light from four Trp 
moieties. Similar antenna effects had been observed for some metal complexes and 
polymers [34-40]. However, to the best of the author's knowledge, this is the first 
observation of such phenomena for NPs. 
Conclusions 
Protein-NP conjugates were made by using glutaraldehyde as a cross-linking 
agent in conjunction with L-cysteine-capping of CdTe NPs. This procedure is expected to 
be applicable to other proteins with exposed Lys moieties primarily targeted by G. While 
simplifying the protein-NP conjugation procedure, it also shows the necessity of a 
protective encapsulation of NP to prevent particle growth and photoinduced 
decomposition. 
An important find was that the coupling process yields preferably BSA-NP 1:1 
diads with some amount of 2: 1 aggregates. These and other analogous products can be 
used as building blocks in more complex protein-based NP suprarnolecules. 
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Figure 11-7. Photoluminescence excitation and UV-vis absorption spectra of BSA-G-
CdTe conjugate (1) and CdTe heated with G at 50 °C 1 hr (2). (a) Excitation spectra. 
Registration wavelength Areg = 580 run. Peaks marked with a star correspond to the 
excitonic transition in CdTe NPs. (b) UV-vis absorption spectra. The inset shows the UV-
vis absorption spectrum ofBSA-G-CdTe conjugate in the visible region of the spectrum. 
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One of the interesting aspects of this work is the demonstration of the efficient 
excitation energy transfer between the protein units and core levels of NPs. This can be 
considered as a communication link between the biological and inorganic components of 
the conjugate. The significance of this observation is the demonstration of a possible 
integration of protein-based self-assembly and information exchange functionalities for 
protein-NP conjugates that can be used in NP-based molecular electronic circuits and 
bioinformatics. 
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CHAPTER III 
ANTIGEN/ANTIBODY IMMUNOCOMPLEX FROM 
CdTe NANOPARTICLE BIOCONJUGATES1 
Introduction 
Recognition at the molecular level is a fundamental characteristic of biochemical 
phenomena such as enzyme catalysis, antibody-antigen interaction, transport, and the 
replication of biological molecules. 
Antigen-antibody interactions have been studied extensively from var10us 
standpoints including immunology, biochemistry, and structural biology [1]. An antigen 
is any molecular species that can be recognized by an animal organism as being foreign 
to itself and which; therefore, triggers the defensive mechanism known as the immune 
response [1,2]. In natural circumstances such antigens are proteins or lipopolysaccharides 
at the surfaces of viruses, bacteria, and microfungi, or at the surfaces of cells and in 
solution in blood or tissues of other species. An antibody is a molecule produced by 
animals in response to the antigen and which binds to the antigen specifically. In 
mammals, two distinct types of molecules are involved in the recognition of antigens. 
These proteins are called immunoglobulins, which are present in the serum and tissue 
1 The content of this Chapter has been published in Nano Letters, 2002, 2(8), p.817-822 
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fluids, and the antigen receptors on the surface of specialized blood cell-the T-
lymphocytes. 
The interaction between antibody and antigen is characterized by relatively high 
affinity and specificity, making this type of reaction a prime candidate for use as an 
analytical tool. 
The purpose of this chapter is the bioconjugation of NPs with proteins as (1) a 
method for their organization in more complex structures and (2) a pathway to new 
sensing and imaging technologies. In this chapter, the preparation of bioconjugates from 
an antigen and an antibody conjugated to NPs of different sizes is described. It is 
demonstrated that the NP-labeled antigen and antibody form an immunocomplex, which 
pairs together NPs with red and green luminescence. In light of programmed assembly of 
nanostructures [3,4] with nanocolloids as building blocks, the similarity of sizes of NPs 
and proteins limits the overall number of affinity ligands around one semiconductor core 
to a few protein units leading to low-valent quantum dots. Such bioconjugates with 
manageable level of complexity can be used as elements of spatially and/or topologically 
organized NP superstructures. 
A practical aspect of this work is related to highly sensitive and specific detection 
by immunoluminescence of various biological and nonbiological analytes of military and 
civilian importance. The excited-state dipole-dipole coupling between NPs of different 
sizes has been observed in the constructed immunocomplex, that results in the excitation 
energy transfer from NPs of smaller diameters to those with larger diameters, (i.e., 
Forster resonance energy transfer (FRET)). The detection limits of analytical processes 
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based on FRET can be as low as 10 ppt with a linear dynamic range from 0.1 to 1000 ppb 
[5,6]. 
A biological component of the conjugates provides highly selective binding to 
cell components [7-13]. The stability of nanoparticles under UV and visible light makes 
possible not only high-contrast multiplexed imaging, [7,14] but also a long-term 
monitoring of the environment for biological warfare agents or natural pathogenic 
organisms such as cholera and Escherichia coli that represent a critical problem for 
countries with limited water treatment capabilities. This can be accomplished by taking 
advantage of the competitive inhibition of FRET in antigen-antibody immunocomplexes 
demonstrated in this chapter. 
A model antibody-antigen system bovine serum albumin (BSA) and 
corresponding antibody (anti-BSA) were chosen. The choice was based on availability of 




Optical absorption spectra were obtained on a Hewlett-Packard 8453 diode array 
spectrophotometer using 1-cm quartz cuvettes. 
Fluorolog 3 and Fluoromax 2 from JY SPEX were used to register the 
luminescence spectra. The right angle registration mode with no intermediate filters was 
utilized in all the measurements. All FRET experiments were carried out after 
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centrifugation of the solutions to remove all particles aggregated due to oxidation and 
coagulation. 
Circular dichroism (CD) spectra were recorded for solutions in 0.01 M PBS 
buffer at pH 7.4 on a JASCO J-500A spectropolarimeter using a JASCO cell of 0.10 cm 
path length. The initial solutions were diluted to approximately 1 mg/mL concentration 
immediately before the spectra were. taken. 
Native and SDS-PAGE gel electrophoresis were performed on the Mini-
PROTEAN 3 electrophoresis cell (Bio-Rad, Hercules, CA) using 4-20% precast Tris-HCI 
gels. 
Gel permeation HPLC experiments were carried out on a HP-1090-II instrument 
equipped with Jordi GPC 500A, 300 mm x 7.8 mm column. Deionized 18 MQ water was 
used as an eluent with a flow rate of 1 mL/min. The optical adsorption signal was 
monitored at 254 nm by a diode array detector. 
Materials and reagents 
All chemicals and biochemicals were from commercial sources and were used 
without further purification. In addition to the materials described in Chapter II, the 
following chemicals were used. Thioglycolic acid, anti-BSA and l-ethyl-3(3-
dimethylarninopropyl) carbodiimide hydrochloride (EDC) were purchased from Sigma -
Aldrich Co. (St. Louis, MO, USA). Antibody (IgG fraction of anti-Albumin [bovine 
serum] [rabbit]) and peroxidase-conjugated rabbit a-bovine immunoglobulin IgG were 
obtained from Rockland (Gilbertsville, PA). N-hydroxysulfo-succinimide (sulfa-NHS) 
and Rhodarnine B were from Fluka (Milwaukee, WI, USA). Sodium carbonate, sodium 
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chloride and potassium phosphate, monobasic were purchased from Spectrum Quality 
Products, Inc. (New Brunswick, NJ). Sodium bicarbonate, sodium phosphate, dibasic and 
potassium chloride were obtained from EM Science (Gibbstown, NJ, USA). Tween 20 
(polyoxyethylenesorbitan monolaurate, water ::S 3%) and OPD tablets were purchased 
from Acros Organics (Fair Lawn, NJ). Linbro/Titertek 96-well E.I.A. microtitration 
plates for ELISA were obtained from ICN Biomedicals Inc. (Horsham, PA). 
Bio-Safe colloidal Coomassie Blue G-250 stain, precast 4-20% linear gradient 
Tris-HCl gel plates used for native and SDS-PAGE electrophoresis, Kaleidoscope and 
SDS-PAGE prestained standards were purchased from Bio-Rad (Hercules, CA, USA). 
Spectra/Por dialysis membranes with MWCO = 12 000-14 000 were from Spectrum 
Laboratories, Inc. (Rancho Dominguez, CA, USA). 
Deionized water (Barnstead) with 18.2 MQ/cm was used for all experiments. 
Synthesis of cadmium telluride nanoparticles 
The details of the synthesis are described in the previous chapter (Chapter II-
synthesis). The only difference is that thioglycolic acid was used as the stabilizer for 
cadmium telluride NPs. 
Mainly, two different NP dispersions were utilized. One with a luminescence 
peak at 553-555 nm and the other one with the peak at 610-611 nm shifting slightly 
depending on the experimental conditions. 
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Conjugation to albumin and anti-albumin 
NP-conjugated BSA and anti-BSA IgG were prepared by the sulfo-NHS (N-
hydroxysulfo-succinimide) and EDC (1-ethyl-3(3-dimethylaminopropyl) carbodiimide 
hydrochloride) reaction (Figure III-1) [ 16-18]. 
The carboxylic acid group of thioglycolic acid stabilized NP forms amide bond 
with the primary amine groups of the protein. NHS-conjugated proteins have shown the 
highest bioactivity among other conjugates as established by several comparative studies 
[19-21], that resulted in the departure from the previously used glutaraldehyde 
conjugation procedure (Chapter II). 
Quantum yield determination 
The quantum yield of NP luminescence was determined by using Rhodamine Bin 
ethylene glycol (Amax= 580 nm, quantum yield 1) as a standard as described in chapter IL 
Optical density of bioconjugates in water and the standard samples of 340 nm, where the 
proteins do not adsorb, were adjusted to be within 0.05 absorbance units with each other. 
The overall optical density of both solutions did not exceed 0.10. 
Detection of NP-BSA antibody by ELISA procedure 
This experiment followed the standard procedure described elsewhere [2]. In 
brief, each well in a 96-well plate (Costar #9018 or Coming #25801EIA/RIA 











I + Sulfa-NHS 
H 
0 
Figure 111-1. EDC/Sulfo-NHS conjugation reaction. 
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in 10 ml coating buffer). Coating buffer was prepared by dissolving 0.78 g Na2C03 and 
1.46 g NaHC03 in 500 ml of H20 with adjusting pH to 9.6. The plate was covered and 
rocked for at least 2 hours (preferably overnight) in an incubator at 37°C. After that it was 
washed 3 times with PBS-Tween 20 buffer in vacuum-apparatus and then patted dry. 
PBS-0.5% Tween 20 buffer was prepared by dissolving 8.0 g NaCl, 0.2 g KH2P04, 2.9 g 
Na2HP04.12H20, 0.2 g KCl, and 0.5 ml Tween 20 (polyoxyethylene sorbitan 
monolaurate) in 1000 L of deionized H20 with adjusting pH to 7.2 - 7.4. Test antibody 
(NP-a-BSA) was diluted in PBS-Tween 20 buffer (normally, one would dilute 25 µl of 1 
mg/ml antibody in 10 ml PBS-Tween 20 buffer to give a 1 :400 dilution, but also one can 
serially dilute 1: 100, 1 :200, 1 :400 etc.). Then 100 µl of prepared solution was added to 
each well and the plate was incubated covered on rocker for 1.5 hours at 3 7 °C. After 
that, it was washed 3 times with PBS-Tween 20 buffer and patted dry. Next, peroxidase-
conjugated rabbit a-bovine IgG was diluted 400 times in PBS-Tween 20 buffer. This 
solution was also added in amount 100µ1 in each well and the plate was incubated as 
before. Then, it was washed 6 times as before and patted dry. Color substrate was 
prepared (OPD - 1 tablet + 20 ml deionized H20 + 15 µl H202) and added 100 µI/well. 
The absorption was recorded in a micro plate reader at 450nm. Controls were set up on 
the same plate. 
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Results and discussion 
Development of the optimal conditions for conjugation 
Different conjugation conditions (i.e. time, temperature, and concentrations) were 
tested and the products were examined by native state electrophoresis and SDS-PAGE. 
The results corresponding to various reaction times at pH = 6. 7 for conjugation 
reaction of NPs and antibody are presented in Figure IIl-2. NP-IgG (anti-BSA) has 
increased mobility do to the high negative charge of NPs. The reaction was finished 
within 4 hours, since the band position of 3 hours (well 2) and 4 hours (well 1) were 
about the same. At pH below 7, the excess NPs in the solution were quenched after the 
reaction, while NPs at pH 7.4 remained active (well 9). However, those NPs conjugated 
with proteins were stable and kept luminescence at pH 6. 7. The bright luminescence on 
the top of well 1-4 is attributed to oligomers of conjugates forming multiple binding sites 
on the NP and lgG. 
The procedure of the reaction time optimization exemplifies the typical process 
for adjusting other parameters such as concentration of EDC. An insufficient amount of 
EDC will result in incomplete conjugation, while the excess of EDC will cause extensive 
cross-linking and aggregation. The ratio of NP to lgG is also a very significant factor that 
requires optimization; deviations from its optimum can also lead to predominant 
formation of oligomers. 
The results corresponding to conjugation reaction of NPs and anti-BSA with 
different EDC and CdTe concentrations at pH 7.0 are presented in Figure III-3. The gel 
electrophoresis procedure was identical to that described above. 
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Figure 111-2. Native state gel electrophoresis of CdTe NPs and NP-IgG (anti-BSA, 
Sigma) with different reaction times at pH 6.7. Left panel : stained by Coomassie Blue. 
Right panel: luminescence image before staining (excitation 360 nm). Wells: L) Standard 
protein ladder; 1) 4 hrs; 2) 3 hrs; 3) 2 hrs; 4) 1 hrs); 5) 30 mjns; 6) no NP, 4 hrs; 7) IgG, 4 
hrs; 8) no IgG, 4 hrs; 9) NP, pH 7.4, 4hrs. (The antibody purchased from Sigma was a 
polyclonal IgG fraction and showed multiple protein bands. The data in this chapter refer 
to anti-BSA from Rockland). 
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Figure 111-3. Native state gel electrophoresis of CdTe and anti-BSA IgG conjugates with 
different EDC and CdTe concentrations at pH 7.0. Left panel: stained by Coomassie 
Blue. Right panel: luminescence image (excitation 360 nm). Samples in wells 1-4 has 
anti-BSA IgG from Sigma, 5-8 has anti-BSA IgG from Rockland; samples in wells 2, 4, 
6, 8 has 0.025 M EDC, while samples in well 1, 2, 5, 7 used 0.05 M EDC; samples in 
well 1, 2, 5, 6 contain 0.025 M NP, while samples in well 3, 4, 7, 8 contain 0.05 M NP; 
well 9 contains IgG from Rockland only. L) Standard protein ladder. 
73 
Considering the data in Figure III-3, it is necessary to point out that IgG from 
Rockland has higher purity as indicated by much fewer low molecular weight bands than 
the one from Sigma. Therefore, the data reported here refer to Rockland anti-BSA IgG. 
BSA samples from different commercial sources were also compared by native gel 
electrophoresis. Within the resolution of this technique, all commercial sources revealed 
approximately the same band structure. 
The following is the optimal protocol developed in the course of this study. A 
reaction mixture containing 0.05 rnM CdTe NP, 1.5-2.5 mg/mL antigen or antibody, 5 
mM NHS, 0.05 M EDC in pH 7.0 PBS buffer was prepared and kept at room temperature 
for 2-4 hrs, then stored at 4 °C overnight. This allowed the unreacted EDC to hydrolyze 
and lose its activity. Next, a small amount of precipitate was formed that probably 
consisted of unconjugated NPs that are known to agglomerate and become non-emissive 
at fairly low pH. The precipitate (if any) was removed by centrifugation. The stock, 
ready-to-use solution of the product was stored at 4 °C. Optionally, it can be dialyzed 
using dialysis membrane with molecular weight cut off (MWCO) 12 000-14 000, in pH 
7.4 PBS buffer; however, the remaining small molecules in non-dialyzed solution did not 
affect the immunocomplex formation as could be seen from ELISA and target-specific 
FRET. 
The luminescence intensity does not decrease after storing the samples at 4 °C for 
over a month. 
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Evidence of conjugate formation 
Native and SDS-P AGE gel electrophoresis 
The native electrophoresis results (Figure 111-4, left panel) showed that both NP-
conjugated BSA (Figure 111-4 well 2) and anti-BSA IgG (Figure 111-4 well 4) bands 
became more mobile in the electric field than the unlabeled biospecific ligands 
(Figure 111-4 well 1 and 3). The BSA monomer band shifted from the relative marker of 
65 k.Da to 4 7 k.Da, evidence that the high negative charge of the NPs and their 
compactness overcame the increase of their mass do to labeling. It is important to 
emphasize, that in the native electrophoresis, the position of the band is not linearly 
proportional to the molecular weight, do to the different charge status of each sample. 
On the gel electrophoresis plate the commercial BSA showed two other bands at 
100 k.Da and 150 k.Da corresponding to BSA-BSA dimer and globulins, respectively. 
This observation agrees with the specifications of Sigma. These compounds had minor 
influence on the biospecific reactions discussed below. Both of these bands shifted 
synchronously with BSA monomer to smaller masses after the NP conjugation. By 
mixing NPs with BSA and IgG without adding coupling reagents (EDC and NHS), no 
evidence of nonspecific binding was observed in native state gels. 
The mobility of the proteins in SDS-PAGE electrophoresis (Figure 111-4, center 
panel), was determined by the mass/charge ratio of denatured protein chains carrying 
sodium dodecyl sulfate (SDS), that imparts a negative charge to them. Interestingly, the 
band positions of NP-labeled and unlabeled proteins virtually coincided at the 65 kDa 






Figure 111-4. Native and SOS-PAGE electrophoresis of CdTe bioconjugates. Left panel: 
native, stained by Coomassie Blue. Center panel: SOS-PAGE, stained by Coomassie 
Blue. Right panel: SOS-PAGE, luminescence image (excitation 360 nm). Wells: (1) 
BSA; (2) red-emitting NP-BSA; (3) anti-BSA IgG; (4) green-emitting NP-IgG; (N) Free 
CdTe NPs; (L) standard protein ladder. Molecular weights are marked on the side in 
kiloOaltons (kDa). 
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mass do to the addition of NPs to the protein was compensated by the increase of the 
overall charge density of the conjugate. Unlike NP-BSA, the SOS-PAGE band ofNP-IgG 
conjugate remained at 150 kDa, while the free IgG were mostly broken apart into small 
molecular weight fragments because of the SDS plus heat action prior to electrophoretic 
separation (Figure III-4, centei panel, wells 3 and 4). 
Considering SDS-PAGE data, it is important to stress two points. 
(1) Estimates of molecular masses on the basis of gel electrophoresis results can 
give erroneous results for bioconjugates from highly charged NPs. Different experimental 
techniques must be used for this purpose. 
(2) Bioconjugation to NP may increase the stability of antibodies. A brief heat 
treatment 150 sec at 96 °C was used for the preparation of SDS-PAGE samples. The 
relative intensity of the SOS-PAGE bands indicated that the conjugated antibodies were 
more resilient to this temperature than the unlabeled ones. The unlabeled antibodies 
(Figure III-4 well 3) were mostly broken apart by SDS and heat into small fragments, 
showing as a band at 40-50 kDa. The NP-IgG conjugates band had significantly lower 
intensity - the antibody remains mostly intact. The latter effect was reproduced in several 
controlled experiments. 
It is important to note that little nonspecific binding of NP and BSA should be 
expected after the SOS-induced denaturation of the protein, and only covalent binding 
could make them move through the gel matrix together. 
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Luminescence of the gel plates 
The evidence supporting covalent conjugation of CdTe to, BSA and IgG was 
found from the luminescence analysis of the gel plates. The bands of NP conjugates 
displayed strong luminescence, while the free proteins did not show any detectable signal 
in the luminescence image (Figure III-4, right panel). Using procedures described in 
Chapter II, the gel pieces cut out of the gel plates in the area of the conjugate bands 
revealed the luminescence spectra with the peaks identical to the original NPs, that is 
553-555 nm and 610-611 nm for NP-IgG and NP-BSA, respectively. 
Chromatography 
The formation of NP bioconjugates was also confirmed by HPLC size exclusion 
chromatography (Figure III-5). The original BSA revealed three HPLC peaks congruent 
to the three bands seen in gel electrophoresis (Figure III-4). Since the species with higher 
molecular weight are eluted in shorter retention times, the observed HPLC peaks at 
retention times 7.8, 6.8, and 5.4 min should be attributed to BSA monomer, BSA dimer, 
and globulins, respectively. After the conjugation to CdTe, the same three peaks could be 
seen at 6.5, 5.3, and 4.2 min, all being shifted to higher molecular weight, as expected for 
the attachment of NPs to proteins. Considering that the approximate molecular weight of 
5.0 nm red-emitting CdTe attached to BSA is 240 kDa (specific density of CdTe is 6.2 
g/cm3), the HPLC peak shift for monomeric BSA shows that not more than one NP is 
attached to this protein. 
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Figure 111-5. HPLC chromatograms for (1) BSA and (2) NP-BSA 
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Similar behavior was observed for the bioconjugates of lgG. The HPLC peak 
attributed to free lgG was observed at 6. 7 min, while shifting to 6.1 min after the 
conjugation to green-emitting NPs of ca. 2.5 nm in diameter. The molecular mass of 
these quantum dots was estimated to be 30 kDa, and; therefore, the HPLC molecular 
weight shift corresponds to the attachment of about one semiconductor particle per lgG 
as well. 
It is necessary to emphasize that the estimates of NP-protein composition of the 
conjugates should be taken with caution because the mechanism of retention of NPs and 
polymers/proteins in gel permeation media can be quite different, and; therefore, 
introduce an error. 
No free BSA or large oligomeric NP-BSA agglomerates with gradually increasing 
molecular masses were detected in elution curves (Figure 111-5). In addition to such 
oligomers, the luminescent bands seen at the starting line in gel electrophoresis could be 
possibly originated from aggregates produced by accumulation on dust particles rather 
than multiple chemical cross-linking because of BSA tendency to adsorb on many 
surfaces [ 15]. 
Biological activity of the conjugates 
Circular dichroism 
Circular dichroism (CD) spectra of BSA and NP-BSA conjugate were very 
similar to each other (Figure 111-6, left panel), which indicates a small disturbance of the 
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Figure 111-6. CD spectra of BSA (left panel) and anti-BSA IgG (right panel) before 
(solid line) and after (dashed line) the conjugation to CdTe NPs. 
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BSA conformation manifested as a shift of CD spectral minimum from 222 to 215 nm 
[22]. Even greater resemblance of CD spectra was observed for anti-BSA and NP-anti-
BSA pair (Figure III-6, right panel). These data show that the tertiary structure of both 
proteins remains mostly intact after the conjugation. 
ELISA 
The binding affinity of the conjugated anti-BSA IgG was examined by the 
standard ELISA technique and the results are shown in Figure III-7. Peroxidase-
conjugated rabbit ::i:;-bovine IgG was used to label the anti-BSA lgG bound to BSA for 
colorized binding count. The absorbance at 450 nm represents the binding activity of the 
antigen/antibody pair. The concentrations of lgG under 1 µg/ml respond linearly, and 
data above 1 µg/ml is saturated (Figure III-7). The binding affinity of NP-IgG was 
determined to be 25-50% that of unlabeled IgG. Its reduction is believed to originate 
from partial blocking of binding sites by (1) NP positioned close to the N terminal of the 
IgG and (2) other bioconjugates in their dynamic aggregates. 
The binding activity of NP-BSA was determined with the same ELISA 
experiments against free polyclonal anti-BSA IgG (results in Figure III-7). No losses of 
binding activity to the antibody in NP-BSA were detected. 
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Formation of the immunocomplex 
Figure III-8 represents the fluorescence spectra of the NP-BSA and NP-anti-BSA 
lgG conjugates in solution. The emission peaks are at the same position as in free NPs. 
The BSA and antibody have no absorption at 340-350 nm and do not fluoresce 
under 340-350 nm excitation. The molar extinction coefficient of free NPs and the 
conjugates at 340 nm is 3 x 108. 
The quantum yield of green-emitting (;\,.max= 555 nm) NP was determined -24%, 
and red-emitting (~ax= 610 nm) NP was -29%. The quantum yield of green-emitting 
NP conjugated to IgG was -6%, and the quantum yield of red-emitting NP conjugated to 
BSA was about -5%. The decrease of the quantum yield should be attributed to the effect 
of low pH required for the EDC/NHS coupling reaction, well known to decrease the 
luminescence of NP stabilized by thiols [23]. 
Significantly higher quantum yields were observed for bioconjugation reactions 
with glutaraldehyde and cysteine-stabilized CdTe, which can be carried out at high pH 
(Chapter II) [24]. 
FRET-resonance energy transfer 
When NP-lgG (anti-BSA) with green luminescence is combined with NP-labeled 
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Figure 111-8. Fluorescence spectra of (1) NP-labeled anti-BSA lgG with green emission 




Figure 111-9. Schema of an immunocomplex formation from NP-labeled antigen and 
antibody. 
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As expected, a significant enhancement of the NP-BSA's red emission at 611 nm 
and the corresponding quenching of the green emission of NP-IgG at 555 nm were 
observed after the self-assembly of the labeled biospecific ligands in the immunocomplex 
(Figure III-10). Concentrations: NP-BSA, 5 x 10-7 M; NP-IgG, 5 x 10-7M; BSA 2 x 10-6 
M. The mutual affinity of the antigen and antibody brought the NPs close enough 
together to allow the resonance dipole-dipole coupling required for FRET to occur. Thus, 
the energy of the excitonic state in the green-emitting NP was transferred to the similar 
state of the red-emitting NP with lower exciton energy. FRET efficiency was particularly 
high for green/red NP pairs because of the strong overlap of their emission and 
absorption spectra. Importantly, when unlabeled BSA was added to the immunocomplex, 
it competitively bound to NP-IgG, thereby replacing it in the immunocomplex with NP-
BSA and inhibiting the FRET process. As such, the green emission peak of NP-IgG at 
555 nm could be observed again, while the red emission peak at 611 nm showed 
decreased intensity. Following this approach, we were able to detect as low as 10-8 M 
BSA with 5 x 10-9 M NP-BSA and NP-IgG. Unlike ELISA, the described detection 
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Figure 111-10. Effect of competitive BSA binding on FRET of the immunocomplex: (1) 
NP-BSA; (2) NP-BSA+ NP-IgG; (3) BSA+ NP-BSA+ NP-IgG. 
88 
Kinetics in immunocomplex 
The kinetics of the competitive replacement of one of the biological ligands in the 
immunocomplex is presented in Figure III-11. Fluorescence emission spectra recorded at 
different times after mixing 10-7 M NP-BSA with 10-7 M NP-IgG (Figure III-11, left 
panel). The intensity of the peak at 553 nm decreases with time while the intensity of the 
peak at 611 nm increases. 
The efficiency of FRET is estimated as the intensity ratio of the red-emission 
peak at 611 nm and green-emission peak at 553 nm. Concentrations: NP-BSA, 10-7 M; 
NP-IgG, 10-7 M; BSA, 5 x 10-7 M; egg albumin, 10-6 M. FRET efficiency decreased and 
the green luminescence became brighter as can be seen by the lower /611//553 ratio 
(Figure III-11, right panel, circles). It takes several hours for the reaction to come to 
completion, that is typical for competitive replacement of noncovalently bound ligands 
with strong affinity to each other. High concentration of egg albumin, that does not bind 
to anti-BSA lgG, showed no influence on FRET between NP-IgG and NP-BSA 
(Figure III-11, right panel, triangles). The time dependence of the immunocomplex 
luminescence remained virtually unchanged as compared to NP-BSA + NP-IgG 
immunoreaction. This fact demonstrates the high biospecificity of the prepared 
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Figure III-11. Left panel: fluorescence emission spectra recorded at different times after 
mixing NP-BSA with NP-IgG. Right panel: kinetics of the immunocomplex formation as 
derived from FRET efficiency. NP-BSA+ NP-IgG (squares), NP-BSA+ NP-IgG + BSA 
(circles), NP-BSA+ NP-IgG + egg albumin (triangles). 
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Summary 
Bioconjugates with complementary antigen and antibody have been -prepared 
from thiol-stabilized green- and red-emitting CdTe NPs. 
They retain substantial bioactivity and can form the corresponding 
immunocomplex and pair NPs with different emission properties in a supramolecular 
assembly. The molecular weight estimates indicate that such a supramolecule combines 
one NPs of each color. 
Quenching of the green-emitting NPs and the enhancement of the luminescence 
of the red-emitting quantum dots signify the presence of FRET in the immunocomplex. 
The exceptional specificity of immunocomplex reactions affords unique possibilities for 
creating organized assemblies of nanoparticles and other nanocolloids. After synthetic 
optimization, such as enhancement of the luminescence quantum yield of the 
bioconjugates, the FRET effect can be taken advantage of in protein sensing and in 
hybrid photoelectronic devices. 
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CELL LABELING WITH NANOPARTICLE BIOCONJUGATES 
Introduction 
Nanostructured materials have a great impact on biological research. An exciting 
application of fluorescent semiconductor nanoparticles is their use in long-term labeling, 
imaging and tracking of cells. 
Recent literature reports indicate that researchers are successfully tackling the 
problems of biostability and functionalization that plagued earlier quantum-dot 
bioconjugates [1] and these particles are now available to label a variety of specific 
cellular targets [2-4]. 
Preparing QDs with associated avidin (streptavidin) allows conjugation of QDs 
with any biotin containing antibody, protein, DNA, or synthetic polymer. QD resistance 
to photobleaching, their ability to be excited at many wavelengths, and their narrow 
emission wavelengths combined with the ready availability of a wide range of 
biotinylated chemicals, biomolecules, and antibodies make avidin conjugated QDs useful 
for additional bioanalytical applications. 
The purpose of the research described in this chapter was to design nanoparticle 
bioconjugates for cell labeling that are photo stable, water soluble and biocompatible. For 
this purpose CdTe-Adivin bioconjugates, and (CdSe)CdS-BSA-Streptavidin were 
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synthesized and analyzed. They have been applied by our collaborators at University of 
Texas Medical Branch (Galveston, TX) for cell labeling. 
Unfortunately, it is difficult to design nanostructured materials to interact 
specifically with cell surfaces. For example, merely attaching peptides to nanoscale 
materials does not completely dictate their interactions with cellular membrane receptors; 
other properties, such as general biocompatibility, solubility and nonspecific interactions 
with cell membranes, have to be correctly engineered as well [5]. 
These nanoparticle-streptavidin (STR) ( or adivin) bioconjugates were further 
conjugated with antibodies anti-CD95 and anti- CD81 in order to target specific cells. 
CD95 is a receptor that is expressed just after irradiation. The idea was to deliver 
nanoparticles to those cells that express CD95 on their surface, because these cells are 
likely to have been damaged by irradiation (for example by irradiation during deep space 
missions). 
Hepatitis C virus is a difficult virus to study since no cell culture models currently 
exist. One of the suggested targets· of this virus is CD81. Therefore, conjugates of NPs-
anti CD81 will target the same cell population that HCV does. This will allow treating 
and pretreating any cell that would likely be infected by HCV. 
Experimental procedures 
Instrumentation 
Emission and excitation spectra were measured on FluoroMax-3 (Jobin Yvon, 
Inc.) spectrofluorometer. 
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UV-visible spectra were recorded with Hewlett-Packard HP8453 diode array 
spectrophotometer. 
Native and SDS-PAGE gel electrophoresis were performed on the Mini-
PROTEAN 3 electrophoresis cell (Bio-Rad, Hercules, CA) using precast gels. 
Materials and reagents 
· The chemicals were used as received from the manufacturers. Cadmium 
perchlorate hydrate, N,N-dimethylselenourea, thioacetamide, L-cysteine, bovine serum 
albumin (BSA), streptavidin (STR) , glutaraldehyde (25 % in water), (1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC), adivin and PBS buffer 
(phosphate buffered saline powder) were purchased from Sigma - Aldrich Co. (St. Louis, 
MO, USA). N-hydroxysulfosuccinimide sodium salt (sulfo-NHS) and rhodamine B were 
obtained from Fluka (Milwaukee, WI, USA). Sodium citrate and sodium hydroxide were 
from Spectrum Quality Products, Inc. (New Brunswick, NJ). 
Bio-Safe colloidal Coomassie Blue G-250 stain, precast 4-20% linear gradient 
Tris-HCl gel plates used for native and SDS-PAGE electrophoresis, Kaleidoscope and 
SDS-PAGE prestained standards were purchased from Bio-Rad (Hercules, CA, USA). 
Spectra/Por dialysis membranes with MWCO = 2,000 and 50,000 were from Spectrum 
Laboratories, Inc. (Rancho Dominguez, CA, USA). 
Deionized ultrapure water (Barnstead) with 18.2 MQ/cm was used for all 
experiments. 
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Synthesis of core-shell CdSe/CdS nanoparticles capped with sodium citrate 
These nanoparticles were synthesized according to the procedure described 
previously [6]. Briefly, 0.05 g of sodium citrate and 2mL of 4xl0-2 M cadmium 
perchlorate were added to 45mL of water and pH was adjusted to 9.0 by 0.1 M sodium 
hydroxide. The solution was bubbled with nitrogen for 10 min. Then 2mL of 1x10-2 M 
N,N-dimethylselenourea was added and the mixture was heated in a conventional 700W 
(Sharp) microwave oven for 55 sec. The molar ratio Cd:Se used in this recipe was 4:1. 
The obtained CdSe nanoparticles were used as the initial material for the 
preparation of core-shell CdSe/CdS NPs according to the following recipe. To a prepared 
volume of CdSe nanoparticle 0.5 mL of 4x 10-2 M solution of thioacetamide 
(thioacetamide was used as a sulfur source) was added in a quantity that the molar ratio 
of Sactded : Seinitiat was 1: 1. The mixture was heated in the sealed round-bottom flask in a 
silicon oil bath at 70-80°C for up to 24 hrs. 
Calculation of the molecular weight and concentration of CdSe/CdS nanoparticles 
Molecular weight (MW) of CdSe/CdS nanoparticles is calculated according to the 
formula: 
MW=p*NA*Vo 
where NA is the Avogadro number, p = 5.81 g/cm3 is the density of cadmium 
selenide [7], and Vo is the volume of one particle that can be calculated, assuming 
spherical particle shape, according to the formula: 
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Vo= 4/ 31rr3 = (nd3)!6 
where r is the radius, d is the diameter of the particle. 
Size of the particles was estimated to be~ 4 nm by TEM (transmission electron 
microscopy). Thus, the volume of one particle Vo will be: 
Vo= (3.14*(4.0*10"9)3)/6 m3 = 3.35 *10-26 m3 = 3.35 *10·20 cm3 
Hence, 
MW(NP) = 5.81 g/cm3 * 6.02*1023 1/mol * 3.35 *10·20 cm3 
= 117,170.27 g/mol;::::; 117,000 g/mol 
The molarity of NP solution was calculated based on the fact that ratio Cd2+: Se2· 
:s2· is equal 4: 1: 1 ( excess of Cd2+) and: 
a) Amount of Se2· in 50 ml of reaction mixture: 
v (Se2") = 0.002 L*O.OlM = 2*10"5 mol 
Since molarity: M = v(Se2")/ V, then: 
M= 2*10"5 mol/0.050 L = 4*10"4 M 
Hence, molarity of CdSe (molecular form)= 4*10"4 M 
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b) Number of CdSe molecules in one nanoparticle: = MW (NP)/MW (CdSe). 
Then number of CdSe molecules in one nanoparticle is equal: 
117,170.27 g/mol / (112.4 +79) = 612 molecules 
c) Finally, molarity of NP solution is equal: 
4*10-4 MI 612 = 6.5 *10-7 M = 0.65 µmol/L 
And number of nanoparticles in 1 ml of solution is equal to: 
M * V *NA= 6.02*1023 1/mol *6.5 *10-7 mol/L * 0.001 L = 3.913*1014. 
Photoactivation of CdSe/CdS nanoparticles 
Freshly made CdSe/CdS nanoparticles dispersions were exposed to ambient light 
for several days (intensity 0.12 mW) in order to enhance their luminescence efficiency. 
Changing the stabilizer from citrate to L-cysteine 
The solution of L-cysteine was added to the prepared core-shell CdSe/CdS NPs in 
the amount that the molar ratio of citrate: cysteine = 10: 1. The mixture was heated at 
50°C for 1hr, and then it was dialyzed against 3.33x10-4 M solution of L-cysteine 
(pH=7.4) for 48 hrs (SpectraPor™ dialysis membranes with MWC0=2000). 
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Conjugation of nanoparticles to bovine serum albumin 
Obtained core-shell CdSe/CdS nanoparticles capped with L-cysteine were 
conjugated to BSA according to one step protocol developed previously (Chapter II). In a 
typical preparation of the BSA-G-CdSe/CdS conjugate, 1 mL of prepared aqueous 
CdSe/CdS was mixed with 2 µL of glutaraldehyde (25% in water = 2.5 M) and 0.25 mL 
of a 0.5 mg/mL solution of BSA in a pH 7.4 phosphate buffer. After the mixture was 
incubated for 1 hr at 50 °C, it was dialyzed ( 48 hrs, using Spectra/Por dialysis membranes 
with MWCO = 50,000) against the PBS and placed in the refrigerator at 4 °C for storage. 
No subsequent treatment with NaCNBH3 was used because the excess of L-cysteine 
present in the mixture as a mild reducing agent converted the initially forming Schiff base 
into the secondary amine bond. 
Final concentrations were estimated as [BSA] O.lmg/mL, or M (BSA) =1.5 
µmol/L, and M (NP)= 0.52 µmol/L, that corresponds to molar ratio NP: BSA= 1 :3. 
Also, CdTe-G-BSA conjugates prepared previously (Chapter II) were used for 
subsequent conjugations. 
Conjugation of NP-BSA to streptavidin/avidin 
The conjugates NP-BSA-STR or NP-BSA-Adivin were prepared using both 
conjugation protocols developed during this study (1) through the G linkage (secondary 
amine bond - see details in chapter II and above) and (2) using zero-linkage agents : N-
sulfo-NHS, with EDC (see details in Chapter III). 
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The glutaraldehyde linkage protocol: To the conjugated NP-BSA, the solution of 
streptavidin ( or adivin) was added to final concentration of streptavidin O. lmg/mL. After 
addition of 5µL glutaraldehyde (25% in water) to the mixture, it was incubated for 1 hr at 
so0 c. 
Zero-linkage conjugation protocol: The water-soluble carbodiimide EDC was 
used to form active ester functional groups with carboxylate groups using the water-
soluble compound· sulfo-NHS. The advantage of adding sulfo-NHS to EDC reactions is 
to increase the stability of the active intermediate, which ultimately reacts with the 
attacking amine. EDC reacts with a carboxylate group to form an active ester (0-
acylisourea) leaving group. Forming a sulfo-NHS ester intermediate from the reaction of 
the hydroxyl group on sulfo-NHS with the active-ester complex extends the half-life of 
the activated carboxylate to hours. Since the concentration of added sulfo-NHS is much 
greater than the concentration of the target molecule, the reaction preferentially proceeds 
through the longer-lived intermediate; however, the final product of this two-step reaction 
is identical to that obtained using EDC alone: the activated carboxylate reacts with an 
amine to give a stable amide linkage (Figure IV-1 ). 
The conjugation in this step followed the modified two-step protocol [8] given 
below. The variation in the pH of activation from the original one-step protocol (pH 7.4) 
provides greater stability for the active ester intermediate. At pH 6 the amines on the 
conjugated molecule will be protonated and; therefore, be less reactive toward the sulfo-
NHS esters that form. In addition, the hydrolysis rate of the esters is dramatically slower 












loss in conjugation potential. To quench the unreacted EDC, usually 2-mercaptoethanol is 
added to form a stable complex with the remaining carbodiimide, according to [9]. In this 
case, the small amount of stabilizing agent (L-cysteine) present in the solution of NP-
BSA conjugates acts as a quencher. 
Briefly, to the solution of streptavidin a quantity of EDC and sulfo-NHS was 
added to obtain final concentrations of 10 mM EDC and 5 mM sulfo-NHS. The solution 
was mixed and reacted for 15 min at room temperature. This activated streptavidin was 
added directly to NP-BSA solution for conjugation. The NP-BSA solution has pH 7.4. 
This brings the pH of the coupling medium above pH 7 to initiate the active ester 
reaction. The mixture was left to react for at least 2 hrs at room temperature in the dark. 
Cell labeling experiments 
Experiments with live cells were carried out by our collaborators at UTMB 
(University of Texas Medical Branch), Galveston, TX. 
To conduct some cell experiments, the prepared NPs conjugates were mixed with 
biotinylated antibodies anti-CD95 and anti-CD81. The product that formed via 
streptavidin-biotin linkage was used to target cell receptors CD95 or CD81. 
For these experiments, different types of cell were used: T24 (human bladder 
carcinoma derived cells), BJAB and MOLT4 (the human cells derived from leukemia 
patients). 
The particles were added to the media. The cells then took up the particles 
through many different methods including pinocytosis, receptor mediated endocytosis, 
etc. 
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TUNEL assay [Terminal deoxynucleotidyl transferase mediated 
dUTP nick-end-labeling] 
This assay has been designed to detect cells dying of apoptosis [ Apoptosis ( from a 
-
Greek word meaning the dropping of leaves from a tree) is a term referring to the 
cytologically observable changes associated with a process of cellular self-destruction 
observed in all eukaryotes]. This widely used and highly sensitive assay is based on the 
fact that nuclear DNA becomes fragmented by endogenous endonucleases during 
apoptosis and that characteristic, nonrandom DNA fragmentation is common to all cells 
undergoing this form of programmed cell death. Fragmented DNA is detected easily by 
agarose gel electrophoresis. 
Results and discussion 
Cadmium telluride (CdTe) bioconjugates 
Experimenting with live cells, conjugates CdTe-BSA-Avidin were initially tested 
to determine their targeting capacity. The resulting conjugates have an emission peak 
maximum at 626 nm (Figure IV -2). 

















Figure IV-2. Photoluminescence emission spectra. 1 - CdTe, cysteine stabilized (PL=580 
nm); 2 - CdTe-albumin (PL=625nm), and 3 - CdTe-albumin-avidin (PL=626nm). 
Excitation wavelength 360 nm. 
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Figure IV-3. NP bioconjugates under UV light. Tube contents (from left to right): 
frozen-dry CdTe - BSA-Avidin; bioconjugate CdTe-BSA - Avidin in PBS buffer 
(pH=7.4); SAA but diluted 1:10 in PBS. 
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The prepared samples of bioconjugates CdTe-BSA-Adivin were further modified 
with anti-human CD95 or anti-human CD81 antibodies via adivin-biotin linkage. The 
obtained conjugates with CdTe core and anti-human CD95 or anti-human CD81 outer 
coatings were initially tested by incubation with cell lines known to express either CD8 l 
or CD95. These experiments were repeated several times, but yielded only sub optimal 
results as assayed by fluorescence microscopy (data not shown). These CdTe NPs were 
most stable at pH>8, and after these experiments, considered to be incompatible with 
media designed for cell culture (pH=7.5). 
Figure IV-4 shows that photoluminescence intensity of both CdTe NPs and 
conjugates CdTe-BSA decreases with decreasing of pH. But the conjugates have higher 
photoluminescence intensity compare to CdTe NPs at the same pH. 
Microinjection of CdTe NPs- Avidin conjugates into live cells 
In order to assess the possibility of using the NPs for intracellular targeting, CdTe 
based bioconjugates were microinjected into T24 cells. Once inside the cells, the NPs 
were assayed for their ability to fluoresce within the cellular compartment. The particles 
did retain their fluorescent properties within the cytoplasm of cells and were 
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Figure IV-4. Luminescence intensity vs. pH for CdTe, cysteine capped, and for 
conjugate CdTe-BSA. 
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Figure IV-5. CdTe NPs coated with BSA/Avidin in PBS. Panel A shows CdTe NPs 
loaded into a pipette prior to microinjection. T-24 cells were microinjected with NPs and 
photographed under light field (Panel B) and fluorescence conditions (Panel C). 
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CdSe/CdS nanoparticles bioconjugates 
In order to overcome disadvantages of the unstable nature of CdTe particles at 
physiological pH, a more stable particle was designed that had different outer layers. The 
particle of choice had, from the core out, a semiconductor CdSe core for fluorescence, a 
CdS coat for stability at physiological pH, and an outer shell of albumin/streptavidin. The 
final coat of streptavidin (STR) gives flexibility with respect to attaching targeting 
molecules to the surface of the particle. Initially, the plan was to use biotin labeled 
antibodies to target cells. Since antibodies are not cost effective for bulk preparation, 
other more cost effective biotin labeled moieties can be used in the future without 
changing the particle preparation. 
The cadmium selenide nanoparticles were synthesized, coated with a layer of 
cadmium sulfide, photoactivated and conjugated first with albumin, and then with 
streptavidin (STR). 
Characterization of CdSe/CdS bioconjugates 
TEM of NP-BSA-STR conjugates 
In order to verify the presence and determine the size of these nanoparticles, TEM 
(transmission electron microscopy) was performed (Figure IV-6). The size of the 
particles present was determined to be -14nm and roughly spherical. 
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20nm -
Figure IV-6. TEM data on CdSe NPs coated with CdS, BSA, and Streptavidin. 
Conjugates were evaluated for size and consistency. The particles appeared to be uniform 
and about 14 nm in diameter. 
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Native gel electrophoresis 
Native Gel Electrophoresis results are shown in Figure IV-7. Since the STR band 
in the last well disappears, STR is consumed. NP-BSA-STR band broadens and slightly 
shifts to heavier molecular weight. · · 
Photoactivation of CdSe/CdS nanoparticles 
Exposure of freshly synthesized CdSe/CdS to ambient light for several days 
(intensity 0.12 mW) was noted to result in a drastic enhancement of the luminescence 
intensity with quantum yield (QY) reaching as high as 25-45%, while no obvious 
increase in photoluminescence was observed for the same NPs stored in the dark. 
(Figures IV-8 and IV-9). 
Similar effects were also reported by several other groups with smaller changes in 
QY. It increased ca. 3 times for thioglycolic acid-capped CdTe NPs illuminated for 5 
days to become 30% [10]. Exposure of CdSe/CdS/ZnS nanorods to laser light overnight 
resulted in a QY increase of luminescence yield from 1 to 16% [11]. A 10% QY was 
obtained after UV curing ZnS:Mn samples coated with polymers [12]. 
For citrate-stabilized CdSe/CdS colloids, the luminescence intensity of the 
excitonic peak typically increased 50-500 times (Figure IV-8 and IV-9). 
Figures IV-8 and IV-9 demonstrate that by exposing the particles to ambient light 
for prolonged period of time (up to three weeks), it is possible to increase the 
fluorescence yield of these particles (Figure IV-9). 
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1 2 3 4 s 6 7 8 
Figure IV-7. Native gel electrophoresis image. Wells: I-Ladder; 2- BSA; 3-
nanoparticles, cysteine stabilized; 4-conjugate NP-BSA; 5-mixture BSA-NP; 6-
STR(streptavidin); 7- mixture conjugate NP-BSA and STR; 8- conjugate NP-BSA-STR. 
Gel =4-20% gradient Tris-HCI precast gel from Bio-Rad, Voltage=85 V, current = 21 
mA, time =2 hours. 
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Figure IV-8. Fluorescent signal of CdSe/CdS-citrate measured after different irradiation 
times in air. Aexc = 380 nm. 
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Figure IV-9. Quantum yield of CdSe/CdS-citrate measured after different irradiation 
times in air. 
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The transition from "dark state" to "bright state" for citrate-stabilized NPs 
involves reaction(s) ofNPs with ambient oxygen; details are being investigated [13]. 
The well-known process of NP photoetching accompanies the photoactivation, 
observed as a gradual blue shift of the luminescence peak for long exposure time. This 
process can be used to control the emission wavelength ofNPs in addition to the original 
synthetic conditions. 
This effect has also been applied in Dr. Kotov' s group for multicolor 
luminescence patterning by photoactivation ofNPs films [14]. 
Here, the effect of photoactivation was applied to make high luminescent NPs 
with potential use for cell tagging. As an example, a photoactivatable variant of the 
Aequorea victoria green fluorescent protein (GFP) was offered to be used as a new tool 
for exploring intracellular protein dynamics by tracking photoactivated molecules in the 
cells [15]. Simplicity of the synthesis of citrate-stabilized CdSe/CdS NPs, tunability, and 
high intensity of their emission provide important advantages over the recombinant 
fluorescent proteins. 
Photoluminescence spectra 
Optical image of NP and conjugates and their emission spectra are shown in 
Figures IV-10 and IV-11 respectively 
The fluorescence intensities have been normalized to the CdSe/CdS bandgap 
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Figure IV-10. Optical image of core-shell CdSe/CdS NPs and their conjugates. From left 
to right: 1. CdSe/CdS, citrate stabilized; 2. CdSe/CdS, cysteine stabilized; 3. Conjugate 
NP-BSA; 4. Conjugate NP-BSA-STR(streptavidin). 
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Figure IV-11. Emission spectra of different stages of conjugation (normalized intensity). 
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fluorescence intensity. The best results for the quantum yield at room temperature 
approximately 12% for citrate stabilized CdSe/CdS, 4% for L-cysteine stabilized 
CdSe/CdS nanoparticles, 20% for NP-BSA conjugates and 8% for conjugate NP-BSA-
STR. 
Initial CdSe/CdS NPs citrate stabilized show maximum luminescence emission intensity 
at 560 nm. Changing the stabilizing agent from labile citrate to L-cysteine leads to a 
decrease in luminescence intensity and blue shift. Such change can be attributed to hole-
acceptor role of sulfur in L-cysteine during binding with a nanoparticle. Sulfur donates 
electrons into the valence zone, where they recombinate with holes decreasing the 
possibility of the recombination electron (from conduction band)-hole (valence band). 
The conjugation with albumin results in recovery of luminescence and further 
blue shift of photoluminescence peak. The increase in emission intensity has been 
attributed to photo-induced healing of the surface states when the surrounding 
environment is equivalent to an insulator with a very high energy barrier, such as an 
organic matrix [16]. 
The final step, conjugation NP-BSA with streptavidin, leads to small red shift and 
shows the decrease in photoluminescence. This can possibly be explained by formation 




Confocal microscopy images are shown on Figure IV-12. CdSe/CdS-BSA-STR 
conjugates tend to form long rod-like objects from 8 to 80 µm long during aging that can 
be easily observed by confocal microscopy. The similar shape aggregates have been 
reported to form from polymers through electrostatic interaction. However, in the present 
case, both proteins as well as NPs are negatively charged (isoelectric points pl-5 for BSA 
and STR). Moreover, the conjugates NP-BSA or NP-STR have not been noticed to 
aggregate with time. Thus the formation of the aggregates should be due to hydrophobic 
interactions or hydrogen bonding or some other type of specific interactions between two 
proteins that should be investigated elsewhere. 
Cell labeling with CdSe/CdS bioconjugates 
N anoparticle cytotoxicity 
Toxicity studies were performed for the conjugates CdSe/CdS-albumin-
streptavidin. The endpoints examined in these studies were membrane integrity and 
apoptosis (Figures IV-13 and IV-14). MOLT4 cells were exposed to NPs for 24 hours 
and cells harvested at 1 and 24 hours for cytotoxicity assays. Harvested cells were 
assayed for membrane integrity at both 1 and 24 hours. Cells harvested at 24 hours were 
also assayed for late stage apoptosis by the TUNEL assay. No notable differences in 
membrane integrity occurred after 1 hour, with respect to the control samples. After 24 
hours; however, there was a remarkable increase in cells with compromised membranes, 
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Figure IV-12. Confocal microscopy data for conjugate NP-BSA-STR. (1) BSA-
Glutaraldehyde-STV(heat); (2) conjugate -4days; (3) conjugate - 11 days; (4) conjugate -
18 days, (5) conjugate - 33 days, (6) conjugate - 39 days. 
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Figure IV-13. Cell viability and TUNEL assays in NP exposed cells. BJAB cells were 
incubated with NPs and cells harvested at 1 (Panels A and B) and 24 hours (Panels C, D, 
E, and F) for both trypan blue dye exclusion (Panels A, B, C, and D) and TUNEL assays 
(Panels E and F). In all time points examined, very few cells had compromised 
membrane integrity. After 24 hours, there appeared to be a modest increase in TUNEL 
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Figure IV-14. Membrane integrity and TUNEL positive cell counts. IO fields of view at 
40x were examined for membrane damage by trypan blue dye exclusion (black and gray 
bars) and TUNEL positive cells (lightest bars) after 1 and 24 hours of exposure to NPs. 
Membrane damage was represented by percent intact, where control cells were 
considered 100% (Control). TUNEL positive, or apoptotic, cells are shown as percent 
apoptotic, where the control cells are <10%. After 24 hours there was a marked loss in 
membrane integrity by the NP exposed cells, with only a modest increase in apoptotic 
cells. 
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shown as a decrease in percent viability when compared to control values. There was also 
a modest increase in late stage apoptotic cells, represented as an increase in percent 
apoptotic (Figure IV-14). 
Coating nanoparticles for targeting and cell entry 
The next step towards targeted delivery of NPs is the addition of targeting 
moieties to the streptavidin coated outer surface. Therefore, streptavidin coated NPs were 
assayed for their ability to bind biotin conjugated antibodies. Protein A coated non-
fluorescent Sum beads were used to bind antibodies either bound or unbound to NPs. 
Protein A is a surface receptor expressed by Staphylococcus aureus and is capable of 
binding the Fe portion of immunoglobulins, especially IgGs, from a large number of 
species [17]. One protein A molecule can bind at least 2 molecules of IgG simultaneously 
[18, 19]. Thus, if the streptavidin on the NPs can bind antibodies, incubation of this 
complex with protein A coated beads should yield fluorescent Sum beads with the same 
spectral characteristics as the NPs. In fact, this experiment did show fluorescent Sum 
beads, but as expected, NPs without antibody did not fluoresce (Figure IV-1 S). Confocal 
microscopy data from this application showed that the NPs were able to remain 
photostable after prolonged exposure to high intensity excitation wavelengths from a 
laser light source. 
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Figure IV-15. Verification of antibody conjugation to CdSe/CdS NPs. Particles made of: 
CdSe core, CdS, BSA, and streptavidin are illuminated with UV light (Panel A). Protein 
A binds the Fe portion of antibodies. CdSe/CdS NPs conjugated to anti-CD95 bound to 
non-fluorescent Protein A coated beads (5µm) (Panel B). NPs not bound to Abs did not 
result in fluorescent Protein A coated beads (data not shown). 
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Nanoparticles targeted to live human cells 
Human cells, BJAB line, constitutively express CD95 on their surface. Since 
CD95 is an early indicator of radiation damage, we conjugated anti-human CD95 
antibodies to the surface of CdSe/CdS NPs. This complex was then incubated with BJAB 
cells for 1 hour at 3 7°C. The resulting cell/NP mixture was washed three times prior to 
examination by confocal microscopy. NP clusters were found on the surface of the live 
human cells and were much brighter than background fluorescence (Figure IV-16). In 
most instances, the NPs appeared to cluster when bound to the cells. Thus, more 
experiments are needed to determine the optimal ratio ofNPs to antibody. 
Photostability of semiconductor nanoparticles attached to human cells 
Prolonged exposure of semiconductor based NPs with high intensity UV laser 
light has been shown to increase fluorescence intensity over that of briefly pulsed NPs 
(Figure IV-17). This experiment was conducted with NPs bound to a living cell. In this 
system, the entire field of view was exposed to a high intensity UV laser beam and 
images taken in regular intervals for >630 seconds. Areas on the resulting images 
containing NPs or unlabeled cell or background were selected and intensity over time 
calculated. The background fluorescence (brown and black lines) quickly decreased, 
while the intensity of the NPs (red and blue) initially increased, then reached a plateau. 
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Figure IV-16. Anti-human CD95 coated CdSe NPs targeted to human cells. BJAB cells, 
which normally express CD95, were labeled with clusters of NPs previously coated with 
anti-human CD95. The cells were exposed to the NPs for 1 hour prior to viewing with a 




Figure IV-17. Effect of prolonged UV exposure on NP fluorescence intensity. The 
fluorescence intensity of NPs increased with prolonged UV laser beam exposure (Areas 1 
and 2; Red and blue lines). Background and autofluorescence intensities (Areas 3 and 4, 
Brown and black lines) decreased initially and then reached a low intensity plateau. 
Overall, the NP clusters increased intensity initially and remained much brighter than the 
background fluorescence for over 630 seconds. 
128 
Optimization of nanoparticle conjugation protocol 
The streptavidin coating is critical for these experiments; therefore, binding of 
streptavidin coated NPs to biotin coated 800 nm non-fluorescent polystyrene beads was 
tested. The success of these reactions was evaluated with confocal microscopy (Figure 
IV-18). In Figure IV-18 the black arrow indicates a bead. From these data, the emission 
spectra of the particles bound to the biotin coated beads were obtained (Figures IV -18 
and IV-19). By using UTMB custom image analysis software, several critical 
measurements were determined (Figures IV-20 and IV-21). Firstly, the relative 
fluorescence intensity was determined of only those NPs bound to beads (Figure IV-20). 
Of those, Sample B, E, and F stood out as the brightest of the bound particles. Figure IV-
21 was derived from a histogram that describes not only intensity, but also the relative 
binding ability of each NP sample. With this data in mind Samples B ( cysteine stabilized 
BSA coated NPs coated with glutaraldehyde conjugated streptavidin) and E ( cysteine 
stabilized NPs coated with NHS conjugated streptavidin in EDC) as the choice method 
for bioconjugation. Additionally, sample E appeared to stay in solution longer, with 






Figure IV-18. NP/streptavidin conjugation methods. Top Panel is Nomarsky scattering 
images, bottom Panel is fluorescence emission from 514 nm laser light. Panel A is beads 
alone, arrow indicated 1 µm biotin coated bead; Panel B is cysteine stabilized BSA 
coated NPs coated with glutaraldehyde conjugated streptavidin; Panel C is BSA coated 
NPs coated with glutaraldehyde conjugated streptavidin dialyzed; Panel D is NPs coated 
with glutaraldyhyde conjugated streptavidin; Panel E is cysteine stabilized NPs coated 
with NHS conjugated streptavidin in EDC; Panel Fis cysteine stabilized BSA coated NPs 
coated with NHS conjugated streptavidin in EDC; Panel G is citrate stabilized NPs 
coated with NHS conjugated streptavidin in EDC; Panel H is citrate stabilized BSA 
coated NPs coated with NHS conjugated streptavidin in EDC. 
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Figure IV-19. Emission spectra of conjugated NPs. Panel A is cysteine stabilized BSA 
coated NPs coated with glutaraldehyde conjugated streptavidin; Panel B is BSA coated 
NPs coated with glutaraldehyde conjugated streptavidin dialyzed; Panel C is NPs coated 
with glutaraldyhyde conjugated streptavidin; Panel D is cysteine stabilized NPs coated 
with NHS conjugated streptavidin in EDC; Panel E is cysteine stabilized BSA coated 
NPs coated with NHS conjugated streptavidin in EDC; Panel F is citrate stabilized NPs 
coated with NHS conjugated streptavidin in EDC; Panel G is citrate stabilized BSA 
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Figure IV-20. NP bound Biotin bead fluorescence. Average intensity of biotin coated 
beads exposed to streptavidin conjugated NPs. Sample A is beads alone; Sample B is 
cysteine stabilized BSA coated NPs coated with glutaraldehyde conjugated streptavidin; 
Sample C is BSA coated NPs coated with glutaraldehyde conjugated streptavidin 
dialyzed; Sample D is NPs coated with glutaraldyhyde conjugated streptavidin; Sample E 
is cysteine stabilized NPs coated with NHS conjugated streptavidin in EDC; Sample F is 
cysteine stabilized BSA coated NPs coated with NHS conjugated streptavidin in EDC; 
Sample G is citrate stabilized NPs coated with NHS conjugated streptavidin in EDC; 
Sample H is citrate stabilized BSA coated NPs coated with NHS conjugated streptavidin 
inEDC. 
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Figure IV-21. Intensity histogram of biotin coated beads exposed to streptavidin coated 
CdSe/CdS NPs. Line A is beads alone; Line B is cysteine stabilized BSA coated NPs 
coated with glutaraldehyde conjugated streptavidin; Line · C is BSA coated NPs coated 
with glutaraldehyde conjugated streptavidin dialyzed; Line D is NPs coated with 
glutaraldyhyde conjugated streptavidin; Line E is cysteine stabilized NPs coated with 
NHS conjugated streptavidin in EDC; Line F is cysteine stabilized BSA coated NPs 
coated with NHS conjugated streptavidin in EDC; Line G is citrate stabilized NPs coated 
with NHS conjugated streptavidin in EDC; Line His citrate stabilized BSA coated NPs 
coated with NHS conjugated streptavidin in EDC. 
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Recombinant peptide and antibody targeted nanoparticles 
Several NP targeting strategies were tested in vitro (Figure IV-22) These data 
suggested that by using a biotinylated fragment of the HIV tat protein, the NPs could 
target to the nucleus of a living human white blood cell (BJAB cell line; Figure IV-22 
panel C). To a lesser extent, a biotin labeled peptide containing only a six Arginine repeat 
could target NPs to the nucleus (Figure IV-22 panel B). Interestingly, the streptavidin 
coated particles alone were somewhat capable of entering the cell (Figure IV-22 panel 
D). Labeling the particles with an anti-CD95 antibody resulted in both outer membrane 
and strong nuclear staining (Figure IV-22 panel E). 
Photostability of recombinant peptide targeted NP bioconiugates compared to a 
traditional Nuclear Dye, Hoechst 33342 
To verify the presence and photostability of the NPs, a photobleaching experiment 
was carried out (Figure IV-23). During this experiment, lasting >400 seconds, the 
fluorescence of the NPs was far more resistant to photobleaching than the potent DNA 
dye Hoechst 33342. 
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Figure IV-22. Nanoparticle targeting. BJAB cells exposed to: A - nothing, B - 6x Arg 
coated NPs; C - HIV Tat coated NPs; D - NPs alone; E - anti-CD95 coated NPs. All 
cells are counterstained with Hoechist 33342 (blue); NPs are green. 
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Hoechst Nanocrystal Hoechst Nanocrystal 
Figure IV-23. Photobleaching experiment data. Live BJAB cells were stained with tat 
tagged NPs (right panels, green) and counterstained with Hoechst 33342 (left panels, 
blue). Photobleaching from Oto 400 seconds. 
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Conclusions 
Semiconductor QDs are currently being developed for the field of biology in 
many different laboratories. These NPs have extraordinary spectral properties that have 
the potential to revolutionize fluorescent imaging. Although these particles hold promise, 
some substantial hurdles exist during their development for use under physiological 
conditions. First few batches ofNPs, composed of CdTe were stable a pH>8. These NPs 
had excellent spectral characteristics and were easy to bioconjugate. Unfortunately, the 
pH requirement precluded their use in tissue culture. The next series of particles were 
composed of a CdSe core particle that was stable at physiological pH. These particles 
were optimized in collaboration with the Leary laboratory (UTMB) and used for the 
experiments with cells. 
The small size of the NPs was probably the biggest factor contributing to their 
ability to enter transfection resistant cell lines, like the MOLT4. This cell line was 
repeatedly exposed to commercial lipid/DNA cocktails and could never be transfected, 
but NPs were able to enter these cells without any special coating. Interestingly, when 
these cells were exposed to NPs, regardless of coating, some of the cells contained large 
amounts of particles while other cells took up no detectable NPs. The original hypothesis 
was that most cells would take up NPs in a dose dependant manner. This hypothesis was 
rejected because in low dose cases only a few cells took up the NPs. These results point 
to a cell regulated uptake of NPs. This cellular characteristic could then be exploited to 
enhance the uptake of these small particles in cells that are notoriously difficult to 
transfect. 
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The next logical step would be to target these particles in vivo. The small size and 
excellent fluorescent properties would be very beneficial during these studies. 
Unfortunately, the CdSe based NPs fluoresce in the green wavelengths. Biological 
material absorbs this region of the spectrum, making green fluorescent probes very 
difficult, if not impossible to use in vivo. 
Therefore, through collaboration with Dr. Kotov and Leary laboratories, a new 
NP, (CdHg/Te) has been developed for biological use. This NP has spectral properties 
similar to the clinical indocyanin dyes that were developed to fluoresce at wavelengths in 
the near infrared. Although these experiments with these particles will not be discussed in 
this dissertation, they are the next step in NP technology. 
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